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Lipopolysaccharide in Gram-negative bacteria and its functions 
 
Most bacteria typically are characterized as being Gram-positive or 
Gram-negative depending on their susceptibility to staining by crystal violet 
stain.  Gram-negative bacteria have a cell wall composed of two 
membranes, the inner membrane and the outer membrane, separated by 
the peptidoglycan containing periplasmic space which distinguishes them 
from Gram-positive bacteria.  The cellular envelope structure can be seen in 
Figure 1.1.  Gram-negative bacteria include a diverse set of many bacteria of 
interest including four of the six so-called “ESKAPE” pathogens, namely 
Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, 
and Enterobacter spp. which cause the majority of nosocomial infections and 
show resistance to many antibacterials.1  Overall, Gram-negative bacteria 
are known to account for approximately 60% of all cases of sepsis.2 
The outer leaflet of the outer membrane of Gram-negative bacteria is 




is also known as endotoxin.  This glycolipid is a major component of the 
outer membrane accounting for about 70% of the outer leaflet.3   
 
 
Figure 1.1. Structure of Gram negative cell envelope.  Representative 
organization of the cellular envelope of the prototypical Gram-negative 
bacterium Escherichia coli.  LPS can be seen in the outer leaflet of the outer 
membrane composing the entirety of the lipids of that leaflet.  [Figure 
adapted from Ref. (10)] 
 
LPS functions in the detection and evasion of host immune cells, 
stabilization of the outer membrane, and resistance to antibiotics 4 and being 
the most external portion of the membrane serves as a first line in 
identification and protection of the cell. Additionally, LPS is a pathogen-
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associated molecular pattern which antagonizes mammalian Toll-like 
receptor 4 at very low concentrations leading to endotoxic shock 
characterized by fever, changes in white blood cell counts, disseminated 
intravascular coagulation, hypotension, shock, and death.5  However, it is 
possible that in order to utilize these antagonistic effects for a positive end, 
and LPS is commonly used as an adjuvant in vaccine therapies.6  Indeed, 
recent studies have been undertaken in order to biosynthetically engineer 
less toxic LPS adjuvants for vaccine therapies.7  In these capacities, LPS 
plays a critical role both in bacterial survival, pathogenesis, and as an 
effective immune stimulating tool.   
Escherichia coli, a Gram-negative bacteria used in research and 
recombinant technologies, is used to generate about 50% of all 
biopharmaceuticals8 with total biopharmaceutical sales in the tens of billions 
of dollars per year.9  The costs to remove endotoxin and methods to 
demonstrate acceptably low endotoxin levels can be exceedingly expensive 
and time consuming.10  Due to the toxicity of LPS, the essentiality for 
survivability and proper function of the bacteria, and a high cost associated 
with LPS removal in biopharmaceuticals, LPS presents an interesting target 







Diversity in core oligosaccharide 
 
LPS is an amphipathic glycolipid composed of three major components 
namely the lipid anchor called Lipid A; the core bridging oligosaccharide, and 
the repeating terminal oligosaccharide called the O-antigen. The Lipid A 
anchor is an acylated disaccharide which is essential to most Gram-negative 




Figure 1.2. Structure of LPS glycolipid.  (A) A representative diagram of 
E. coli K-12 MG1655 LPS with each component bracketed.  Each color 
represents a unique monosaccharide showing the inner core region 
composed entirely of Kdo (orange) or heptose (green).  (B)  The molecular 
structure of the most conserved portion of LPS in Enterobacteriaceae 
composed of Hep-Kdo2-Lipid A. 
 
Repeating O-antigen 
Outer Core Region 





forms.11  Attached to the Lipid A is the core oligosaccharide which is typically 
quite similar within closely related species.  The final portion, the O-antigen, 
is highly variable even from subspecies to subspecies and is commonly not 
found in typical laboratory strains.12  Endotoxicity of LPS is known to be 
associated strictly with the Lipid A portion of the molecule. Lipid A in most 
species cannot be fully acylated, and thereby made endotoxic, without the 
addition of the first sugar in the oligosaccharide core.13  The core 
oligosaccharide typically starts with the addition of 2-keto-3-deoxy-D-
manno-octulosonic acid (Kdo) which is a unique eight carbon sugar which is 
typically also essential for survivability.14  In some species the Kdo is 
substituted by a closely related eight carbon sugar analog.  The number of 
Kdo analogs added varies from species to species typically between one to 
four, with E. coli incorporating two Kdo moieties.  The overall structure of 
LPS from E. coli can be seen in Figure 1.2.  The addition of the Kdo moieties 
allows the final addition of the final acyl groups by LpxL and LpxM yielding 
the endotoxic species Kdo2-Lipid A.15  For wild-type E. coli this is the minimal 
species required for survival although mutants have been generated which 
can survive without this requirement.16  As such, proteins involved in the 
biosynthesis of Kdo2-Lipid A represent an attractive target for antibacterial 
development.   
Core oligosaccharide is typically divided into the early core and the late 
core wherein the early core is highly conserved between many disparate 
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species and the late core is much more variable.  In E. coli as well as most 
known Enterobacteriaceae and many Gram-negative species the addition of 
Kdo is followed by the addition of a number of L-glycero-D-manno-heptose 
moieties17, comprising the early core, followed by a diverse set of other six 
carbon monosaccharides, making up the late core.18  Cells lacking these 
sugars, while still viable, show increased susceptibility to hydrophobic 
antibiotics and increased susceptibility to phagocytosis by macrophages.19, 20  
Due in large part to the limited diversity seen in the early core region of LPS, 
its antigenic properties for vaccine studies as well as development of 
inhibitors of its biosynthesis have recently been undertaken.21-24  Therefore, 
an understanding core oligosaccharide biosynthesis and the ability to 
generate and design unique analogs is of increasing interest today. 
 
Dissertation Research Rationale 
 
LPS core oligosaccharide is a diverse glycolipid with many known 
biological functions.  Understanding the effects of diversity in the 
oligosaccharide has to date been a major challenge due to the complexity of 
the molecule and the many genes involved in its generation.25  In order to 
address this problem, we developed a strain of Gram-negative bacteria 
which lacks the ability to elaborate the lipid IVA precursor to LPS in order to 
generate various glycoforms, both natural and novel, within a common and 
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easy to use Gram-negative cell line.  We hypothesized that deletion of the 
genes involved in LPS core biosynthesis would allow for heterologous 
expression of genes from other Gram-negative species.  This would allow for 
the generation and study of many LPS glycoforms that could not be easily 
generated with any other modern system. Utilizing this new cell line, we 
were able to create multi-glycosylated Lipid IVA species by heterologous 
expression of Kdo and heptosyltransferases.  Using this system we were able 
to gain insights into functionalities of these proteins and mechanistic insights 
into the function of Kdo transferases. 
In order to expand our understanding of early core biosynthesis, we 
decided to explore the selectivity and incorporation of the Kdo analog, Kd8N 
(8-carbon amino sugar 8-amino-3,8-dideoxy-D-manno-octulosonic acid) 
from Shewanella oneidensis. Utilizing a series of in vitro and in vivo 
experiments, we determined the cytidylyltransferase from S. oneidensis has 
selectivity for Kd8N over Kdo, but a cell line lacking Kd8N will incorporate 
Kdo into the LPS core.  This leads us to conclude that the overall selectivity 
stems from the presence or absence of available Kd8N in the cell rather than 
absolute selectivity of the enzymes themselves.  With this knowledge, we 
can move forward to study properties of the incorporation of this interesting 
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Construction and applications of an E. coli strain lacking  
LPS core biosynthetic genes 
Summary 
 
Lipopolysaccharide (LPS) is an essential glycolipid found in Gram-
negative bacteria that has many medical and biological functions and 
applications.  Many of these key features are due to the presence of an 
oligosaccharide core attached directly to the main Lipid A anchor.  The 
oligosaccharide core varies from species to species and can often be quite 
complex making it hard to study properties of each core as well as the 
activities and selectivities of the enzymes involved in LPS core biosynthesis.  
WOD02 is the first viable E. coli strain lacking all glycosyltransferases 
involved in LPS core biosynthesis that is capable of generating new non-
native glycoforms of oligosaccharide core.  This system allows for generation 
of various glycoforms using a simple, non-pathogenic E. coli background 
forgoing the need of slow-growing, pathogenic bacteria for many 
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downstream applications.  Using this system, we now report 
characterizations of heptosyltransferases from four Gram-negative bacteria 
and insights into the mechanism of the 2-keto-3-deoxy-D-manno-
octulosonic acid transferase.  Additionally, use of this cell-line gives evidence 
to the presence of a Lipid A-3’-acyloxylacyl deacylase in E. coli K-12 with 




Gram-negative bacteria have an asymmetric outer membrane wherein 
the majority of the outer leaflet is composed of the essential and unique 
glycolipid lipopolysaccharide (LPS), or endotoxin.1-3  LPS is the major surface 
antigen in Gram-negative bacteria and is composed of three major 
components, namely lipid A, core oligosaccharide, and O-antigen.4  The lipid 
A portion is the region of least variability between different species and is 
often a hexaacylated disaccharide molecule.  The core oligosaccharide is the 
linking region between the lipid A moiety and the O-antigen and typically 
shows little variability between closely related species.  The most variable 
region of LPS is the often repeating oligosaccharide, O-antigen, often 
comprised of repeating oligosaccharide subunits. O-antigen can vary widely 
even within different strains of the same species and is often not present in 
13 
 
common laboratory strains of Gram-negative bacteria such as in Escherichia 
coli K-12 MG1655.5, 6   
The unique eight carbon sugar 2-keto-3-deoxy-D-manno-octulosonic 
acid, Kdo, is found in the majority of LPS glycoforms7 in Gram-negative 
bacteria and serves to bridge the Lipid A portion with the core 
oligosaccharide. For wild-type Escherichia coli a minimal LPS structure, Kdo2-
Lipid A or Re-LPS, is required for survivability of the cell line4, 8.  The 
attachment of Kdo is catalyzed by the enzyme Kdo transferase, WaaA#, 
utilizing the activated sugar nucleotide CMP-Kdo. WaaA depending on the 
species could be mono-9, 10, bi-11-13, tri-14, or tetra-functional14, 15 
transferring either one, two, three, or four Kdo molecules, respectively, to 
the tetra-acylated Lipid A precursor, Lipid IVA. The mechanism and 
selectivity by which multifunctional Kdo transferases function is currently not 
known.  Work by Chung and Raetz has shown that the functionality of Kdo 
transferases can be changed by swapping a few amino acids between the 
Kdo transferases of Haemophilus influenzae and E. coli showing that the 
functionality is enzyme specific.16  Additionally, previous research in our lab 
determined the first crystal structure of a WaaA from Aquifex aeolicus co-
crystallized with the substrate analog CMP17 giving insight into the binding of 
substrate.  However, the mechanism dictating the number of Kdo subunits 




Figure 2.1. Biosynthesis of Early LPS core. Biosynthetic scheme of the 
early modification of Lipid IVA in E. coli K-12 including the glycosylation by 
WaaA, fatty acid acylation by LpxL and LpxM to generate the endotoxic Lipid 
A anchor followed by heptosylation by WaaC. 
 
After the addition of the Kdo moieties in E. coli, the late 
acyltransferases, LpxL and LpxM, transfer the final fatty acids to the Kdo2-
Lipid IVA giving the hexaacylated Kdo2-Lipid A.18  For some species this 
simple Kdo glycosylated Lipid A is the complete LPS, such as with Chlamydia 
trachomatis19, while most other species further elaborate of the core 
15 
 
oligosaccharide.  In E. coli as in most Enterobactericeae, the next step is the 
addition of the seven carbon sugar L-glycero-D-manno-heptose catalyzed by 
the heptosyltransferase I, WaaC20  The pathway from Lipid IVA to the first 
heptosylation is shown in Figure 2.1.  The inability to transfer this heptose in 
mutant E. coli strains leaves the cells with the ability to generate solely 
Kdo2-Lipid A.21 This phenotype is known to cause increased susceptibility to 
hydrophobic antibiotics and increased susceptibility to phagocytosis by 
macrophages.22  This makes Lipid A biosynthesis and incorporation of these 
unusual sugars into LPS interesting targets for novel antibacterial 
development.23-25  Additionally, vaccines of the highly conserved inner core 
of some species such as Neisseria meningitidis26, 27 are under investigation 
for use as a vaccine antigen in addition to the longstanding use as an 
adjuvant.28 
Unfortunately, to be able to study the selectivity of the enzymes 
involved in core biosynthesis, and to be able to generate these inner cores for 
downstream applications, it is often necessary to culture virulent, slow-
growing bacteria.  In order to develop a cell line capable of generating inner 
core oligosaccharides not found in wild type E. coli, we attempted to delete 
the genes involved in core oligosaccharide biosynthesis we adopted a strategy 
that took advantage of a unique mutant of E. coli, KPM56.10 This cell line was 
chosen as it is capable of surviving with only Lipid IVA due to the presence of 
the phenotypic suppressor mutant in a gene of unknown function, yhjD400.29  
16 
 
The cell line WOD02 which lacks all core oligosaccharide biosynthetic genes is 
reported herein and is capable of biosynthesizing early inner core structure 





Bacterial Strains, Plasmids, and Growth Conditions. All strains and 
plasmids used in the present study are described in Table 2.1.  Standard 
cultures of E. coli were routinely grown aerobically with shaking (250 rpm)  





KPM56 E. coli K-12 MG1655 F- rph+ fnr+ ΔgutQ ΔkdsD yhjD400 kdsD+ 
ΔwaaC ΔwaaA 
10 
WOD01 KPM56 Δ(waaF-waaA)::kan This study 
WOD02 KPM56 Δ(waaF-waaA) This study 
WOD03 WOD02 + pETduet1 (empty vector) This study 
WOD04 WOD02 + pHiA (carrying H. influenzae waaA gene) This study 
WOD05 WOD02 + pEcA (carrying E. coli waaA gene) This study 
WOD06 WOD02 + pCtA (carrying C. trachomatis waaA gene) This study 
WOD07 WOD02 + pCpA (carrying C. psittaci waaA gene) This study 
WOD08 WOD02 + pHpC (carrying H. pylori waaC gene) This study 
WOD09 WOD02 + pEcC (carrying E. coli waaC gene) This study 
WOD10 WOD02 + pCjC (carrying C. jejuni waaC gene) This study 
WOD11 WOD02 + pAaC (carrying A. aeolicus rfaC1 gene) This study 
WOD12 WOD02 + pHiAHpC (carrying H. influenzae waaA and H. pylori 
waaC gene) 
This study 
WOD13 WOD02 + pHiAEcC (carrying H. influenzae waaA and E.coli 
waaC gene) 
This study 





WOD15 WOD02 + pHiAAaC (carrying H. influenzae waaA and A. 
aeolicus rfaC1 gene) 
This study 
WOD16 WOD02 + pEcAHpC (carrying E. coli waaA and H. pylori waaC 
gene) 
This study 
WOD17 WOD02 + pEcAEcC (carrying E. coli waaA and E. coli waaC 
gene) 
This study 
WOD18 WOD02 + pEcACjC (carrying E. coli waaA and C. jejuni waaC 
gene) 
This study 
WOD19 WOD02 + pEcAAaC (carrying E. coli waaA and A. aeolicus rfaC1 
gene) 
This study 
WOD20 WOD02 + pCtAHpC (carrying C. thracomatis waaA and H. 
pylori waaC gene) 
This study 
WOD21 WOD02 + pCtAEcC (carrying C. thracomatis waaA and E. coli 
waaC gene) 
This study 
WOD22 WOD02 + pCtACjC (carrying C. thracomatis waaA and C. jejuni 
waaC gene) 
This study 
WOD23 WOD02 + pCtAAaC (carrying C. thracomatis waaA and A. 
aeolicus rfaC1 gene) 
This study 
WOD24 WOD02 + pCpAHpC (carrying C. psittaci waaA and H. pylori 
waaC gene) 
This study 
WOD25 WOD02 + pCpAEcC (carrying C. psittaci waaA and E. coli waaC 
gene) 
This study 
WOD26 WOD02 + pCpACjC (carrying C. psittaci waaA and C. jejuni 
waaC gene) 
This study 
WOD27 WOD02 + pCpAAaC (carrying C. psittaci waaA and A. aeolicus 
rfaC1 gene) 
This study 
pET26b KanR; T7 expression vector Novagen 
p26HpC Helicobacter pylori J99 waaC inserted into NdeI/BamHI sites of 
pET26b 
This study 
p26EcC E. coli K-12 waaC inserted into NdeI/BamHI sites of pET26b This study 
p26CjC Campylobacter jejuni NCTC 11168 waaC inserted into 
NdeI/BamHI sites of pET26b 
This study 
p26AaC Aquifex aeolicus rfaC1 inserted into NdeI/BamHI sites of 
pET26b 
This study 
pUM211 pET16b containing the waaA gene from H. influenzae I69 10 
pUM212 pET16b containing the waaA gene from E. coli K-12 10 
pFEN207 AmpR; pUC8 plasmid containing the waaA gene from C. 
trachomatis L2 
30 
pUM210 pET16b containing the waaA gene from C. psittaci 6BC 10 
pETduet1 AmpR; T7 expression vector for dual gene expression Novagen 
pHiA Haemophilus influenzae I69 waaA inserted into NdeI/XhoI of 
pETduet1 
This study 
pEcA E. coli K-12 waaA inserted into NdeI/XhoI of pETduet1 This study 
pCtA Chlamydia trachomatis L2 waaA inserted into NdeI/XhoI of 
pETduet1 
This study 
pCpA Chlamydophila psittaci 6BC waaA inserted into NdeI/XhoI of 
pETduet1 
This study 
pHpC H. pylori J99 waaC inserted into XbaI/BamHI sites of pETduet1 This study 
pEcC E. coli K-12 waaC inserted into XbaI/BamHI sites of pETduet1 This study 
pCjC C. jejuni NCTC 11168 waaC inserted into XbaI/BamHI sites of 
pETduet 1 
This study 
pAaC A. aeolicus rfaC1 inserted into XbaI/BamHI sites of pETduet1 This study 
18 
 
pHiAHpC H. influenzae I69 waaA inserted into NdeI/XhoI and H. pylori 
J99 waaC inserted into XbaI/BamHI sites of pETduet1 
This study 
pHiAEcC H. influenzae I69 waaA inserted into NdeI/XhoI and E. coli K-
12 waaC inserted into XbaI/BamHI sites of pETduet1 
This study 
pHiACjC H. influenzae I69 waaA inserted into NdeI/XhoI and C. jejuni 
NCTC 11168 waaC inserted into XbaI/BamHI sites of pETduet 1 
This study 
pHiAAaC H. influenzae I69 waaA inserted into NdeI/XhoI and A. aeolicus 
rfaC1 inserted into XbaI/BamHI sites of pETduet1 
This study 
pEcAHpC E. coli K-12 waaA inserted into NdeI/XhoI and H. pylori J99 
waaC inserted into XbaI/BamHI sites of pETduet1 
This study 
pEcAEcC E. coli K-12 waaA inserted into NdeI/XhoI and E. coli K-12 
waaC inserted into XbaI/BamHI sites of pETduet1 
This study 
pEcACjC E. coli K-12 waaA inserted into NdeI/XhoI and C. jejuni NCTC 
11168 waaC inserted into XbaI/BamHI sites of pETduet 1 
This study 
pEcAAaC E. coli K-12 waaA inserted into NdeI/XhoI and A. aeolicus rfaC1 
inserted into XbaI/BamHI sites of pETduet1 
This study 
pCtAHpC C. trachomatis L2 waaA inserted into NdeI/XhoI and H. pylori 
J99 waaC inserted into XbaI/BamHI sites of pETduet1 
This study 
pCtAEcC C. trachomatis L2 waaA inserted into NdeI/XhoI and E. coli K-
12 waaC inserted into XbaI/BamHI sites of pETduet1 
This study 
pCtACjC C. trachomatis L2 waaA inserted into NdeI/XhoI and C. jejuni 
NCTC 11168 waaC inserted into XbaI/BamHI sites of pETduet 1 
This study 
pCtAAaC C. trachomatis L2 waaA inserted into NdeI/XhoI and A. aeolicus 
rfaC1 inserted into XbaI/BamHI sites of pETduet1 
This study 
pCpAHpC C. psittaci 6BC waaA inserted into NdeI/XhoI and H. pylori J99 
waaC inserted into XbaI/BamHI sites of pETduet1 
This study 
pCpAEcC C. psittaci 6BC waaA inserted into NdeI/XhoI and E. coli K-12 
waaC inserted into XbaI/BamHI sites of pETduet1 
This study 
pCpACjC C. psittaci 6BC waaA inserted into NdeI/XhoI and C. jejuni 
NCTC 11168 waaC inserted into XbaI/BamHI sites of pETduet 1 
This study 
pCpAAaC C. psittaci 6BC waaA inserted into NdeI/XhoI and A. aeolicus 
rfaC1 inserted into XbaI/BamHI sites of pETduet1 
This study 
pKD46 AmpR; λ Red recombinase expression plasmid 31 
pKD4 AmpR, KanR; template plasmid for kanamycin resistance 
cassette 
31 
pCP20 AmpR, CmR; FLP recombinase expression plasmid 31 
HpWaaCfor gattctagaattcatATGAAAATAGCGATTGTCAGGCTTTCAG This study 
HpWaaCrev gaattcggatccTCATTCTTTTTCCTTTAAAACGTTTAAAACGC  This study 
EcWaaCfor gattctagaattcatATGCGGGTTTTGATCGTTAAAAC This study 
EcWaaCrev gaattcggatccTTATAATGATGATAACTTTTCCAAAACTGC This study 
CjWaaCfor tatacatATGATCTTTTTTTATTATTTTTTAACTTGGACGGC This study 
CjWaaCrev atatggatccTTATAAGCTTTTTCTTGCATCAATTCCC This study 
AaRfaC1for gattctagaattcatATGAAGAAGGCGTTAATAGTGAGG  This study 
AaRfaC1rev gaattcggatccTTACGGCTTGGTATTCAAAATGTTTATAG This study 
HiWaaAfor atatatatcatATGTGGCGTTTTTTTTATACCAGCT This study 
HiWaaArev atatctcgagTCATACATTGCGCTCCAAATAAGG This study 
EcWaaAfor actccatATGCTCGAATTGCTTTACACCG This study 
EcWaaArev cagtctcgagTCAATGCGTTTTCGGTGGC This study 
CtWaaAfor gattctagaattcatATGATAAGACGTTGGTTAACATCTCG This study 
CtWaaArev gaattcctcgagTTAGATTTTCATGCAAGTAATTTGGCTC This study 
CpWaaAfor actgcatATGGTGGGGCTTCCTAGGATT This study 
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WaaFKOforseq CCGTTCAAAACCGTTGCTGAAG This study 
WaaAKOrevse
q 
CGC GTC ACG ATA TCG ATA TGA CC This study 
 
at 37 °C in LB medium (10 g/liter Bacto-tryptone, 5 g/liter yeast extract, 10 
g/liter NaCl). When necessary, kanamycin (30 µg/ml), chloramphenicol (30 
µg/ml), or ampicillin (100 µg/ml), was added to the media. 
DNA Methods. Standard recombinant DNA methods were used for 
nucleic acid preparation and analysis. 32 Primer sequences are listed in Table 
2.1. To construct gene deletions, the phage λ Red recombinase procedure of 
Datsenko and Wanner was used as described31, except plasmids pKD46 and 
pCP20 were cured at 37 °C to accommodate the temperature sensitive 
phenotype of lipid IVA-expressing E. coli derivatives.33 For generation of a 
cell line lacking all genes involved in core oligosaccharide biosynthesis, 
WaaFfor and WaaArev were used to generate the KAN resistance cassette 
from pKD4 which targeted the gene region from the nucleotides 3794929-
3809817 which includes the genes waaF, waaC, waaL, waaU, waaZ, waaY, 
waaJ, waaR, waaB, waaS, waaP, waaG, waaQ, and waaA within three 
separate operons.  The gene clusters are seen in Figure 2.2.  Transformation 
of this linear cassette into KPM56/pKD46 afforded the kanamycin-resistant 
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strain, WOD01.  Removal of the kanamycin resistance gene by curing with 
pCP20 afforded the strain WOD02. 
 
 
Figure 2.2. Waa gene cluster.  The gene clusters containing the waa 
genes involved in core oligosaccharide biosynthesis 
 
To clone the heptosyltransferases, HpwaaC (jhp_0264), EcwaaC 
(b3621), CjwaaC (cj1133), and AarfaC1 (aq_1542) from H. pylori J99, E. coli 
K-12 MG1655, C. jejuni Strain NCTC 11168, and A. aeolicus VF5, 
respectively, into pET26b and the Kdo transferases HiwaaA, EcwaaA, 
CtwaaA, and CpwaaA from H. influenzae I69, E. coli K-12 MG1655, C. 
trachomatis L2, and C. psittaci 6BC, respectively, into pETduet1, the 
appropriate primers were chosen.  For the heptosyltransferases the 
appropriate genomic DNAs were used as templates, while for the Kdo 
transferases pUM21110, pUM21210, pFEN20730, or pUM21010 were used as 
the appropriate templates.  The heptosyltransferases were subcloned into 
the multiple cloning site of pET26b using the restriction sites for NdeI and 
BamHI while the Kdo transferases were subcloned into pETduet1 using the 
restriction sites NdeI and XhoI.  In order to use pETduet1 to coexpress both 
a heptosyltransferase and a Kdo transferase each of the four pETduet1 
plasmids containing each Kdo transferase gene were cut with XbaI and 
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BamHI removing the promoter and ribosomal binding site of the empty 
multiple cloning site.  The pET26b plasmids containing the 
heptosyltransferases were similarly restricted giving a fragment carrying the 
promoter region, ribosomal binding site, and heptosyltransferase gene.  
These fragments were subcloned into the Kdo transferase containing 
pETduet1 or a similarly digested empty pETduet1 plasmid giving a total of 
24 pETduet1 plasmids generated.  These plasmids underwent DNA 
sequencing to verify sequences of the desired genes.  Each pETduet1 
plasmid were transformed into WOD02 by electroporation. 
Cell growth for LPS Production. Transformed cells were grown on 
LB agar plates supplemented with 100 µg/mL ampicillin. A 2 mL culture of 
liquid LB medium, also supplemented with ampicillin, was inoculated from 
single colonies at 37°C overnight with shaking at 200 rpm. This culture was 
diluted 1:100 in 200 mL fresh LB medium and incubated at 37°C, 200 rpm 
overnight. Cells were then sedimented by centrifugation at 4000 x g, 4°C, 
30 min (Eppendorf Centrifuge 5804R). The resulting pellet was resuspended 
in 30 mL of phosphate buffered saline before being recentrifuged. The cells 
were then resuspended in 20 mL of ethanol and stirred at 4°C overnight. 
Cells were once again centrifuged before being resuspended in 20 mL of 
acetone which was left at 4oC stirring for 2 h. This process of centrifuging, 
resuspending in acetone, and stirring was repeated once more.   The 
suspension was centrifuged a final time.  To the resulting biomass was 
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added a small volume of diethyl ether to make a slurry which was subjected 
to filtration by indirect vacuum.  The biomass was left to dry overnight and 
then pulverized to a homogenous fine particulate. 
LPS purification. LPS samples were purified by a modified version of 
the phenol-chloroform-petroleum ether procedure34 as reported previously.35 
The dried samples were weighed and resuspended into LPS-free water 
(Braun water) to a concentration of 1 mg/mL for mass spectrometry analysis 
and TLR4 activation assays. 
Electrospray-Ionization Fourier-transformed Ion Cyclotron 
Mass Spectrometry. LPS samples (1 mg/ml) were diluted 15-fold in a 
solution consisting of 50% 2-propanol supplemented with 4 mM 
triethylamine and 0.35 mM acetic acid resulting in a pH of approximately 
8.5. All samples were analyzed in the negative ion mode using a Q Exactive 
Plus instrument (Thermo, Bremen, Germany) with Electrospray Ionization 
(ESI). Samples were delivered with a syringe pump at a flow rate of 5uL/min 
using a sheath gas flow of 5L/min, transfer capillary temperature of 250C 
and a S-lens level of 100. Spectra were recorded at highest resolution 
(280,000 FWHM defined at m/z 200) with no further collisional activation or 
all ion fragmentation activated with NCE set to 25V.  All mass spectra can be 
found in Appendix B. 
23 
 
TLR4 stimulation assays. Using the diluted LPS samples, TLR4 
activation was assayed using the HEK-Blue™ hTLR4 and HEK-Blue™ Null2 
cells in accordance with the specifications of the supplier of the cell lines 




Construction of chromosomal deletion of LPS core 
oligosaccharide biosynthesis. The cell line KPM56 was chosen for the 
construction of an E. coli mutant lacking the genes involved in core 
oligosaccharide biosynthesis based on its ability, as well as that of its 
progenitor KPM2233, to survive chromosomal deletions of genes required for 
LPS biosynthesis such as kdsD, gutQ, waaA, and waaC.  Additionally, unlike 
in many species of Gram-negative bacteria, E. coli K-12 MG1655 contains all 
genes in core oligosaccharide biosynthesis in a single gene cluster37 thereby 
facilitating removal in this cell line.  Two of these genes, namely, waaA and 
waaC were removed from KPM56 previously.  In total, 14 genes have been 
removed by the Datsenko-Wanner method from this gene cluster leaving 
hldD, the gene encoding ADP-L-glycero-D-mannoheptose epimerase and 
coaD, the gene encoding pantethine-phosphate adenylyltransferase intact, 
as confirmed by DNA sequencing of this region.  This generates a cell line, 
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named WOD02, capable of generating the appropriate sugar precursors of 
core biosynthesis, but lacking the capability to transfer these sugars to the 
Lipid IVA molecule. Unlike the KPM56 progenitor, WOD02 forms highly 
mucoid colonies on standard LB-miller agar plates.  This mucoid morphology 
is likely related to colonic acid production due to lack of WaaL as reported 
previously.38 
WOD02 is capable of expressing non-native inner core. With a 
blank template in hand, we turned our efforts toward verifying the number 
of Kdo glycosylation events catalyzed by the WaaA of various Gram-negative 
bacteria and toward probing the substrate specificities of WaaC, the next 
enzyme in the biosynthetic pathway of a number of diverse microorganisms.  
For example, one would assume that a WaaC from an organism that displays 
two Kdos would not glycosylate a mono-Kdo glycosylated Lipid A species 
since no such species have been observed in their native organism.  This 
approach, therefore, would determine if a microorganism in which WaaC 
normally glycosylates a single Kdo-Lipid A would transfer a heptose to a di- 
or tri-Kdo glycosylated species.  Novel, as well as natural, LPS molecules 
would likely result from this study.   
The approach was to first introduce a WaaA from an organism which 
has been seen to have mono-, bi-, tri-, or tetrafunctional activity with H. 
influenzae9, E. coli11, C. trachomatis14, and Chlamydophila psittaci15, 








Table 2.2. Functionalities of Kdo and heptosyltransferases.  (A) Table 
showing functionalities observed by each Kdo transferase expressed in the 
WOD02 system.  A + represents glycoform was seen and a – represents no 
glycoform of that type seen.  (B) Table showing modification of the Kdo 
containing glycoform by the addition of a single heptose by each 
heptosyltransferase.  A + represents that the glycoform was detected in a 
WOD02 cell line expressing the corresponding heptosyltransferase and a – 
represents no corresponding glycoform detected. 
 
Kdos displayed in this cell line.  It should be noted that various atypical E. 
coli glycoforms with one, two or three Kdos have been previously observed39, 
40 and as such in the samples unique Kdo glycosylation is not necessarily 
expected.    
To create a matrix as well as probe the substrate specificities, four 
different WaaCs was co-expressed in tandem with the WaaA in each of the 
above stains containing the various Kdo derivatives.   The 
heptosyltransferases were chosen based on predicted specificity and possible 
enhanced promiscuity.  The results from the various combinations and 
permutations are listed in Table 2.2a and 2.2b and discussed below. 
Kdo transferase Kdo-Lipid IVA Kdo2-Lipid A Kdo3-Lipid A 
HiWaaA + - - 
EcWaaA + + + 
CtWaaA + + + 
CpWaaA + + + 
Heptosyltransferase Hep-Kdo-Lipid IVA Hep-Kdo2-Lipid A Hep-Kdo3-Lipid A 
HpWaaC + + - 
EcWaaC + + + 
CjWaaC - + - 
AaRfaC1 + - - 
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In order to verify the ability of WOD02 cells to generate glycoforms 
from other Gram-negative bacteria, the LPS of WOD02 was purified and 
analyzed by electrospray ionization Fourier transform ion cyclotron mass 
spectrometry in negative ion mode (see Appendix B for all mass spectra).  
As expected, this cell line lacking the waa gene cluster was unable to 
glycosylate LPS giving major peaks of 1404.85 u and 1527.86 u for only 
Lipid IVA (1,4’-bisphosphorylated tetraacylated Lipid A, calculated mass 
1404.854 u) and the phosphoethanolamine (P-EtN) modified Lipid IVA 
(calculated mass 1527.862 u), respectively which is similar to the LPS found 
in the related cell lines KPM22,33 and KPM56.10  The cell lines WOD03 (Empty 
Vector), WOD08 (HpWaaC), WOD09 (EcWaaC), WOD10 (CjWaaC), and 
WOD11 (AaRfaC1) which all lack Kdo transferases all show a similar 
production of Lipid IVA and P-EtN-Lipid IVA which demonstrates that neither 
the vector alone nor any of the heptosyltransferases can cause modification 
of the truncated LPS.   
WOD02 cells heterologously expressing Kdo transferases, namely 
WOD04 (HiWaaA), WOD05 (EcWaaA), WOD06 (CtWaaA) and WOD07 
(CpWaaA), all have restored ability to transfer Kdo to Lipid IVA wherein 
WOD04, WOD05, WOD06, and WOD07 all show a peak of 1624.91 u 
representing a single Kdo attached to Lipid IVA (Kdo-Lipid IVA, calculated 
mass 1624.912 u). Additionally, WOD04, WOD05, and WOD06 show each 
contain an M+1 peak, 2018.28 u, for the diacylated Kdo-Lipid IVA, Kdo-Lipid 
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A (calculated mass 2017.277 u). WOD05 and WOD06 showed an M+1 peak 
at 2238.34 u which corresponds to Kdo2-Lipid A (calculated mass 2237.336 
u), and WOD06 also shows the presence of the triglycosylated Kdo3-Lipid A 
(M+1 exact mass 2458.40 u, calculated mass 2457.39 u).  Although 
CpWaaA has been shown previously to have tetrafunctional Kdo transferase 
activity39 no samples were seen to contain the peak for Kdo4-Lipid A 
(calculated mass 2677.45 u).  Other Kdo transferase activities could be more 
readily seen in other samples, namely, the presence of Kdo3-Lipid A in 
WOD17 (EcWaaA and EcWaaC) and the presence of Kdo2-Lipid A in WOD24 
(CpWaaA and HpWaaC), WOD26 (CpWaaA and CjWaaC), and WOD27 
(CpWaaA and AaRfaC1) and Kdo3-Lipid A in WOD24. The summary of the 
activities of the Kdo transferases used are found in Table 2.2a.  In all, it was 
seen that with the heterologous expression of Kdo transferases in the 
WOD02 cell line, it is possible to generate either mono-, bi-, or tri-
functionalized LPS analog. 
In order to further modify these initial glycosylated strains, the Kdo 
transferases were coexpressed with putative heptosyltransferase I enzymes 
from various species.  The WaaC of Helicobacter pylori was chosen because 
while the Kdo transferase is bifunctional giving two Kdo moieties attached to 
the Lipid IVA, the distal Kdo is removed by a Kdo hydrolase.  This 
modification is believed to help H. pylori evade the host immune system.12 
Due to the presence of both Kdo-Lipid IVA and Kdo2-Lipid IVA it was 
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speculated that the heptosyltransferase I of H. pylori may have enhanced 
promiscuity.  The heptosyltransferase I from E. coli was chosen both a 
control due to it being the best characterized heptosyltransferase I to date 
as well as the only WaaC whose structure has been determined.41  E. coli 
WaaC is also known to transfer a heptose to Kdo2-Lipid A, Kdo3-Lipid A,42 or 
a fully deacylated Lipid A analog.43   The third heptosyltransferase I chosen 
was from the Campylobacter jejuni whose truncated LPS has been seen to 
have been composed of Hep-Kdo-Lipid A44 or Hep-Kdo2-Lipid A45 leading to 
the possibility of enhanced WaaC promiscuity.   The last enzymes chosen 
were RfaC1 (gene: aq_1543) and RfaC2 (gene: aq_145) from the 
hyperthermophilic Aquifex aeolicus as a putative heptosyltransferases.  Both 
genes in A. aeolicus are annotated as ADP-heptose: LPS 
heptosyltransferases.  Although the structure of full LPS of A. aeolicus is 
unknown, analysis of the LPS from the related species, A. pyrophilus, gave 
evidence for the presence of two heptose molecules in the LPS core.46 This 
would lead one to believe that A. aeolicus rfaC1 and rfaC2 encode not for 
two heptosyltransferase I enzymes but instead one being a 
heptosyltransferase I and the other a heptosyltransferase II. The Kdo 
transferase of A. aeolicus is known to transfer only a single Kdo10, and as 
such it is speculated that the heptosyltransferase I of A. aeolicus will only 
transfer to a single Kdo.   
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Using the aforementioned Kdo transferases coexpressed with HpWaaC 
yielded heptose modification as follows.  WOD12 (HiWaaA and HpWaaC) and 
WOD24 show the presence of Hep-Kdo-Lipid IVA (exact mass 1816.98 u, 
calculated mass 1816.975 u).  WOD20 (CtWaaA and HpWaaC) on the other 
hand show the presence of Hep-Kdo2-Lipid A (M+1 exact mass 2430.40 u, 
calculated mass 2429.399 u).  
For EcWaaC the presence of Hep-Kdo-Lipid IVA can be seen in WOD13 
(HiWaaA and EcWaaC), WOD17 (EcWaaA and EcWaaC), and WOD25 
(CpWaaA and EcWaaC).  WOD17 and WOD21 (CtWaaA and EcWaaC) both 
show the presence of Hep-Kdo2-Lipid A.  Additionally, WOD21 also shows the 
presence of the larger Hep-Kdo3-Lipid A (M+1 exact mass 2650.46 u, 
calculated mass 2649.458 u).   
CjWaaC can only generate Hep-Kdo2-Lipid A at any sufficient quantities 
as in WOD22 (CtWaaA and CjWaaC).   
On the contrary AaRfaC1 shows the least promiscuity generating only 
Hep-Kdo-Lipid IVA in WOD15 (HiWaaA and AaRfaC1), WOD19 (EcWaaA and 
AaRfaC1), WOD23 (CtWaaA and AaRfaC1), and WOD27.  The summary of 
the activities of the heptosyltransferases used in these experiments are 
shown in Table 2.2b.  With these genes it is now possible to generate Hep-
Kdo-Lipid IVA, Hep-Kdo2-Lipid A, and Hep-Kdo3-Lipid A in vivo in WOD02. 
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WOD02 shows a putative 3’-O-Deacylase activity. LPS samples 
from a number of the Kdo transferase and heptosyltransferase expressing 
WOD02 cell lines contained peaks which correspond to Kdo2-LATetra (exact 
mass 1800.94 u, calculated mass 1800.944 u), which is the 3’-O-deacylated 
Kdo2-Lipid A wherein the 3’-acyloxylacyl moiety has been removed.  This 
peak is seen in all of the tested EcWaaA expressing cell lines (WOD05, 
WOD17, WOD18, and WOD19) in all CtWaaA expressing cell lines (WOD06, 
WOD20, WOD21, WOD22, and WOD23) as well as two of the CtWaaA 
expressing cell lines (WOD26 and WOD27).  Additionally, a peak which 
corresponds to the heptosylated Kdo2-LATetra, Hep-Kdo2-LATetra (M+1 exact 
mass 1994.01 u, calculated mass 1993.007 u) was seen in three samples 
(WOD17, WOD20, and WOD21). Kdo2-LATetra was previously reported47 in 
the mutant E. coli F515 which is known to be deficient in heptosyltransferase 
activity giving Kdo2-Lipid A as a maximal LPS structure.48 
Endotoxicity. In order to verify the lack of endotoxic product in the 
WOD02 cell line as well as to show the ability to return endotoxicity with the 
addition of Kdo transferases hTLR4/MD-2 activation was assayed by 
subjecting HEK-Blue™ hTLR4 and HEK-Blue™ Null2 cells to purified LPS 
samples. With HEK- Blue™ Null2 being the parent strain of HEK-Blue™ 
hTLR4 lacking the TLR4, MD-12, and CD14 needed to elicit the NF-κB 
mediated response.  Activation of the TLR4 complex by LPS induces 
production of the reporter protein, secreted embryonic alkaline phosphatase 
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(SEAP).  The phosphatase activity was measured using a colorimetric 
substrate with an absorbance reading at 655 nm.  Percent activation was 
determined based on the highest reading of the E. coli K-12 LPS at 1000 
ng/mL. 
Activation of hTLR4 for LPS samples purified from WOD03 which lacks 
all glycosyltransferases for core region biosynthesis is seen in Figure 2.3, to 
be the lowest of all samples tested with lower than 2% activity compared to 
full E. coli K-12 LPS at the same concentration.  It is also shown that the 
addition of Kdo transferases help return hTLR4 activation to these cells.  The 
addition of only a single Kdo (seen in WOD04) returns low hTLR4 activation 
while all other cell lines containing Kdo transferases show a higher return of 
hTLR4 activation.  A comparison of each Kdo transferase with each 
heptosyltransferase (see graphs in Appendix C, Figure C.1A-D) show that in 
general, the addition of a heptosyltransferase for EcWaaA, CtWaaA, and to a 
lesser extent CpWaaA seems to have little to no difference on the overall 
hTLR4 activation.  The cell lines containing HiWaaA on the other hand seem 
to vary more widely based on heptosyltransferase.  While this change in 
activation is quite clear, the underlying reason for this is unknown, and may 
be an artefact of change in overall lipid yield or activation of late 
acyltransferases.  It is sufficient to say from this data though that the LPS 




Figure 2.3. Effect of WaaA activity on hTLR4 activation.  Measure of 
hTLR4 activation by SEAP secretion.  Total activities are compared to 
commercial full-length E. coli K-12 LPS (100% activation).  Samples include 
WOD02 with empty vector (WOD03), or expressing HiWaaA (WOD04), 
EcWaaA (WOD05), CtWaaA (WOD06), or CpWaaA (WOD07)  
 
acyltransferases.  It is sufficient to say from this data though that the LPS 
produced inherently by the WOD background has very low hTLR4 activation 
when compared to wild type E. coli LPS, and that in general, the addition of 
a Kdo transferase allows a return of hTLR4 activation of the purified LPS 



























































 The ability to quickly and easily generate a series of glycoforms of LPS 
has to date been a challenge.  Many tools exist to study Kdo transferases10, 
49 but to study biosynthetic genes beyond Kdo is much less straight forward.  
Due to the importance of LPS both for the bacteria containing it as well as 
for its endotoxic properties, a cell line lacking all core oligosaccharide 
biosynthetic genes was desired.  By removing all waa genes within the same 
gene cluster in a unique strain previously produced in our laboratory wherein 
Lipid A was no longer the minimal LPS structure required for E. coli K-12 
survival29, 33 the new WOD02 cell line was generated.  With the ability of 
WOD02 to continue to produce Kdo, it was possible to reintroduce Kdo 
transferase genes from other species into this cell line in order to study their 
functionalities.  Indeed, when the four Kdo transferases used in this study 
were introduced into WOD02, they were able to return Kdo glycosylation 
activity to the cells.  Each Kdo transferase was able to modify the Lipid IVA 
to produce the expected glycoforms with the exception of the Kdo 
transferase from C. psittaci which in this system was unable to generate the 
tetraglycosylated Lipid IVA glycoform.  The lack of full glycosylation by this 
particular enzyme is potentially due to lack of WaaZ activity in this cell line 
as WaaZ has been shown to be required for addition of more than two Kdo 
moieties in wild-type E. coli.40, 50  Although WOD02 was unable to tetra-
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glycosylate Lipid IVA, the cell line was able to generate mono-, bi-, or tri- 
Kdo glycosylated analogs.  Through hTLR4 activation, it is shown that 
WOD02 would have very low endotoxic activity alone, but the addition of a 
Kdo transferase greatly increases endotoxicity due to the activities of the 
acyltransferases, LpxL and LpxM, which are known to typically require Kdo 
glycosylation of Lipid IVA. 
 As the study of heptosyltransferases has to date typically been limited 
to the native WaaC42 or studying the enzyme in vitro43, the generation of the 
WOD02 cell line is a useful tool to study different combinations of Kdo 
transferases with heptosyltransferases in a Gram-negative in vivo 
environment.  With a pETduet system, combinations of both very important 
early core biosynthetic genes were generated and analyzed.  With this 
system, it has been shown that typically the substrate specificities of these 
enzymes are quite broad with all tested heptosyltransferases modifying a 
single Kdo glycosylated Lipid IVA species.  Three of the tested 
heptosyltransferases, HpWaaC, EcWaaC, and CjWaaC further would 
glycosylate Kdo2-Lipid A, and EcWaaC continuing on to glycosylate Kdo3-
Lipid A.  For HpWaaC and CjWaaC, these studies are the first reports to our 
knowledge of their substrate specificities.  H. pylori LPS is particularly of 
interest due to the presence of the Kdo hydrolase not found in most Gram-
negative bacteria which allows removal of a Kdo moiety in biglycosylated 
Kdo2-Lipid A.  This study shows that HpWaaC is able to heptosylated the 
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growing LPS core potentially before or after the cleavage of the distal Kdo by 
the Kdo hydrolase.  The ability to do this could be a remnant of evolution or 
could mean that H. pylori may at times maintain bi- Kdo glycosylated LPS. 
AaRfaC1 is seen for the first time to be a heptosyltransferase I is 
unique among those tested in having specificity only for Kdo-Lipid IVA as a 
substrate.  This would leave one to believe that AaRfaC2 would most likely 
then have heptosyltransferase II activity, but this is yet to be seen.  As the 
full structure of the LPS of A. aeolicus is not currently know, this gives us 
novel insight into the potential core oligosaccharide of this unique bacterium.   
The presence of AaRfaC1 in samples containing Kdo2-Lipid A or Kdo3-
Lipid A were not further glycosylated.  Due to the activity of AaRfaC1, we 
gain an indirect view of Kdo transferase activity as multi-functional Kdo 
transferases must go through either an iterative or processive mechanism.  
In an iterative mechanism, the WaaA would bind to the lipid acceptor 
molecule, glycosylate, and then release only to rebind later for further 
glycosylation.  In a processive mechanism, the WaaA would remain bound to 
the lipid acceptor until the correct number of Kdo glycosylation events occur 
where upon the glycosylated lipid is then released.  As the WaaA from A. 
aeolicus is monofunctional, it is quite likely that AaRfaC1 would only be able 
to detect a single Kdo glycosylated Lipid IVA.  In order for heptosylation to 




Figure 2.4. LpxR-like deacetylation.  Deacylase activity such as that 
caused by S. typhimurium LpxR leads to loss of the 3’-acyloxoacyl group of 
Lipid A. 
 
the WOD02 cell line, the Kdo transferases must be undergoing an iterative 
glycosylation mechanism whereby each glycosylation event is followed by a 
release of the acceptor allowing for the heptosyltransferase to bind and 
transfer the heptose.  
An additional feature seen in the LPS analysis of WOD02 expressing 
Kdo and heptosyltransferases is the presence of a 3’-O-deacylated Kdo2-
LAtetra.  LpxR from Salmonella typhimurium has been found to have 3’-O-
deacylation activity although no homologues have been found in E. coli K-
12. Nevertheless, heterologous expression in E. coli elicits 3’-O-deacylation 
(Figure 2.4).51  The activity of LpxR activity is known to cause reduced TLR4 
activation, and is likely a method by which cells can evade a host immune 
system.52  This activity has been seen before47 in another E. coli LPS mutant.  
Additionally, this activity is only seen in Kdo2-LAtetra or Hep-Kdo2-LAtetra both 
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of which are native E. coli LPS core structures.  It is quite possible that this 
putative deacylase activity is a response to stress on the outer membrane 
caused by truncated LPS.  Further studies are needed to identify and genes 
involved and to study how this modification is activated in E. coli. 
In summary, WOD02 represents a new tool for the study of LPS core 
biosynthesis.  This cell line allows for the characterization of biosynthetic 
genes, generation of various LPS core oligosaccharides, and potentially 
serves as a tool to study LPS peripheral modifications.  This cell line could be 
used further to generate large oligosaccharides by continuation of the 
methods herein of heterologous gene expression.  Additionally, the ability to 
generate these novel glycoforms could help with the generation of complex 
glycolipids as antigens for future vaccine research and aid in our efforts to 
eliminate bacterial infections. 
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Insights into the selective incorporation of 8-amino-3,8-dideoxy-D-




 The LPS of Shewanella species are unique among Gram-negative 
bacteria in that they contain the 8-carbon amino sugar 8-amino-3,8-
dideoxy-D-manno-octulosonic acid (Kd8N) in their core lipopolysaccharide.  
This sugar is biosynthesized from the 8-hydroxy sugar (Kdo) commonly 
found in the LPS core of most other Gram-negative bacteria.  The method by 
which S. oneidensis selectively incorporates Kd8N into its core 
oligosaccharide over Kdo is not known.  Herein we test the substrate 
specificities of both the activating enzyme (KdsB or Kdo cytidylyltranferase) 
and the glycosyltransferase (WaaA or Kdo transferase).  KdsB is shown in 
vitro to prefer its native substrate, Kd8N, while WaaA in vivo does not have 
a substrate preference.  A mutant strain of S. oneidensis lacking the ability 




These observations suggest that KdnA and KdnB expression may ultimately 




Shewanella oneidensis and related species in the genus are common 
marine Gram-negative bacteria that are of interest due to their unique 
bioremediation properties including the ability to reduce heavy metals1 as 
well as the ability to reduce azo dyes.2  Bacteria in the genus are also known 
to be opportunistic pathogens3 and are known to be involved in the spoilage 
of fish.4  Shewanella spp. represent an interesting genus of bacteria with 
very unique biological properties and an important set of metabolic 
functions.5 
Shewanella oneidensis as with other Gram-negative bacteria contain 
an amphipathic glycolipid, lipopolysaccharide or LPS, found in the outer-
leaflet of the outer membrane.  These glycolipids are composed of the Lipid 
A anchor, the bridging oligosaccharide core, and the repeating O-antigen.6  
The Shewanella genus is unique in that it is the only known genus to 
incorporate 8-amino-3,8-dideoxy-D-manno-octulosonic acid (Kd8N) rather 
than 3-deoxy-D-manno-octulosonic acid (Kdo) into the oligosaccharide core 




Figure 3.1. Structures of Kdo analogs. Structures of Kdo analogs.  (A) 
Kdo, (B) Kd8N, (C) Kd8Z, (D) the KdsB inhibitor 2,3,8-trideoxy-8-amino-β-
D-manno-octulosonic acid 
 
occurring date Shewanella putrefaciens is the only naturally occurring 
species in this genus which has been shown to incorporate Kdo into the 
LPS.8  Kdo is of interest due to being essential in most known Gram-negative 
strains with the minimal LPS structure, Kdo2-Lipid A, being necessary for 
most wild-type E. coli strains.  The presence of the 8-amine group is striking 
due to the inhibitory properties seen in the Kd8N analog 2,3,8-trideoxy-8-
amino-β-D-manno-octulosonic acid, a KdsB inhibitor and one of the few 
known Kdo biosynthetic pathway inhibitors.9-11  Kdo and some pertinent 
analogs are shown in Figure 3.1.  Understanding the selectivity of Kd8N over 
Kdo could yield interesting insights for the development of novel Kdo analog 
inhibitors for future antibacterial development. 
Recent work by Gattis et al. showed the biosynthetic genes necessary 
for generation of Kd8N in S. oneidensis, namely the alcohol dehydrogenase 




Figure 3.2. Kd8N biosynthesis and potential selectivity.  Biosynthetic 
scheme for generation of Kd8N by the alcohol dehydrogenase, KdnB and the 
aminotransferase, KdnA.  In S. oneidensis due to the potential presence of 
both Kdo and Kd8N, either Kdo or Kd8N should be able to be activated by 
the cytidyltransferase, KdsB generating either CMP-Kd8N or CMP-Kdo.  
These activated sugar nucleotides can then be transferred to Lipid IVA (fatty 
acid content of E. coli Lipid IVA shown for simplicity) generating either Kd8N-
Lipid IVA or Kdo-Lipid IVA, respectively. 
 
The crystal structures of the corresponding proteins were recently 
determined.13  When a S. oneidensis ΔkdnA ΔkdnB strain was constructed it 
remained viable but showed a slight increase in susceptibility to polymyxin B 
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and bile salts12 suggesting that Kd8N may not be essential for survivability.  
The function of Kd8N in the LPS of Shewanella is not currently known, but it 
is suspected to play a role in membrane integrity and resistance to 
polycationic peptides similar to that found by the addition other cationic or 
zwitterionic LPS modifications such as 4-amino-4-deoxy-L-arabinose14 or 
phosphoethanolamine.15, 16  
When S. oneidensis was subjected to click-mediated fluorescent 
labeling experiments utilizing the Kdo analog 8-azido-3,8-dideoxy-D-manno-
octulosonic acid (Kd8Z), it was the only Gram-negative strain tested which 
didn’t show any labeling of the outer membrane.17  The authors speculated 
that the lack of fluorescence was due to the use of Kd8N rather than Kdo in 
the LPS of S. oneidensis.  Knowing now that Kd8N is biosynthesized from 
Kdo, it would seem that S. oneidensis must have some mechanism by which 
to selectively incorporate Kd8N rather than Kdo, or even Kd8Z, into the core 
of the growing LPS oligosaccharide.  The selectively in S. oneidensis could 
come from complete turnover of Kdo into Kd8N by KdnB and KdnA, 
substrate specificity of the activating enzyme (Kdo cytidylyltranferase or 
KdsB), or substrate specificity of the glycosyltransferase which modifies the 
Lipid IVA precursor (Kdo transferase or WaaA).  The pathway of Kd8N 
biosynthesis and routes of selectivity are show in Figure 3.2.  The KdsB of S. 
oneidensis MR-1 (gene: SO_2478) shares a sequence identity of 45% with 
the KdsB of E. coli (see alignment, Figure 3.3).  While the WaaA of S. 
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oneidensis MR-1 (gene: SO_4676) shares a sequence identity of 47% with 
the WaaA of E. coli (see alignment, Figure 3.4).  Neither the KdsB nor the 
WaaA show any obvious variation that would cause a selective preference for 
one sugar over another.  In order to elucidate the substrate selectivity of 
KdsB and WaaA from S. oneidensis in vivo and in vitro studies were 
undertaken. 
 
Figure 3.3. Alignment of KdsB from S. oneidensis and E. coli.  
Alignment of KdsB from S. oneidensis and E. coli with identities shown in red 




Figure 3.4. Alignment of KdsB from S. oneidensis and E. coli.  
Alignment of WaaA from S. oneidensis and E. coli with identities shown in 





Bacterial Strains, Plasmids, and Growth Conditions. All strains 
and plasmids used in the present study are described in Table 3.1.  Standard 
cultures of E. coli were routinely grown aerobically with shaking (250 rpm)  
 





E. coli TOP10 F- mcrA Δ(mrr-hsdRMS-mcrBC) φ80lacZΔM15 ΔlacX74 nupG 





E. coli str. B F– ompT gal dcm lon hsdSB(rB–mB–) λ(DE3 [lacI 
lacUV5-T7p07 ind1 sam7 nin5]) [malB+]K-12(λS) 
18 
S. oneidensis Shewanella oneidensis Venkateswaran et al. ATCC® 
700550™ 
ATCC 
SoΔAB S. oneidensis ΔkdnA-kdnB 12 
KPM56 E. coli K-12 MG1655 F- rph+ fnr+ ΔgutQ ΔkdsD yhjD400 
kdsD+ ΔwaaC ΔwaaA 
19 
pET16b pET expression vector carrying an N-terminal His•Tag® 
sequence followed by a Factor Xa site 
Novagen 
pET19b pET expression vector carrying an N-terminal His•Tag® 
sequence followed by an enterokinase cleavage site 
Novagen 
pET21b pET expression vector carrying an N-terminal T7•Tag® 





pET16b containing SoWaaA inserted in the NdeI and BamHI This study 
pET19b-
SoKdsB 





pET19b containing EcKdsB inserted in the NdeI and BamHI 
sites 
This study 





pCR2.1-kdsD pCR2.1-TOPO plasmid containing S. oneidensis kdsD This study 
pCR2.1-kdsA pCR2.1-TOPO plasmid containing S. oneidensis kdsA This study 
pCR2.1-kdsC pCR2.1-TOPO plasmid containing S. oneidensis kdsC This study 
pCR2.1-kdnB pCR2.1-TOPO plasmid containing S. oneidensis kdnB This study 
pCR2.1-kdnA pCR2.1-TOPO plasmid containing S. oneidensis kdnA This study 
pCR2.1-
kdnA-ndeIX 
pCR2.1-TOPO plasmid containing S. oneidensis kdnA with 




pK8N-1 pET21b with AvrII inserted into the multiple cloning site This study 
pK8N-2 pK8N-2 containing kdsD inserted in NdeI and BamHI sites This study 
pK8N-3 pK8N-2 containing kdsA inserted in NdeI and BamHI sites This study 
pK8N-4 pK8N-2 containing kdsC inserted in NdeI and BamHI sites This study 
pK8N-5 pK8N-2 containing kdnA with internal NdeI sites removed 
inserted in NdeI and BamHI sites 
This study 
pK8N-6 pK8N-2 containing kdnB inserted in NdeI and BamHI sites This study 
PK8N-7 pK8N-2 containing kdsA fragment from pK8N-3 inserted in 
the XbaI and HindIII sites 
This study 
pK8N-8 pK8N-7 containing kdsC fragment from pK8N-4 inserted in 
the XbaI and HindIII sites 
This study 
pK8N-9 pK8N-8 containing kdnB fragment from pK8N-5 inserted in 
the XbaI and HindIII sites 
This study 
pK8N-10 pK8N-8 containing kdnA fragment from pK8N-5 inserted in 




pUC57-SoK8N containing kdsD, kdsA, kdsC, kdnA, and kdnB 
codon optimized for E. coli, KanR 
Genscript 
EcKdsBfor GAATTCTAGAATTCATATGAGTTTTGTGGTCATTATTCC This study 




SoKdsBrev GAATTCGGATCCAAGCTGCAGTTAATCAACGGCTAAACGTTG This study 
SowaaAfor GATTCTAGAATTCATATGAATCGATTTTTTTACAGTGCGCTGC This study 







kdsDfor GATTCTAGAATTCATATGGTAGACCAATCACAATTGCGCCAATG This study 
kdsDrev GAATTCGGATCCAAGCTGCAGTTAAATGACTCCCGCTTTAAC This study 
kdsAfor GATTCTAGAATTCATATGAGTAATAAAATCATAAAGTTAG This study 
kdsArev GAATTCGGATCCAAGCTGCAGTTATTTGCTGGTATCAATTG This study 
kdsCfor GATTCTAGAATTCATATGCCACAGCAAGGATTTTACG This study 
kdsCrev GAATTCGGATCCAAGCTGCAGTTATATGCTCATCCCATGG This study 




kdnBfor GATTCTAGAATTCATATGAGTTTTAAAAATTTTAAAGTAGTTG This study 








TTGAAGCTGGTGTACCGTAATGA This study 
SokdnAmut1
brev 








GATAACGCCCACATGTTCTCCGAT This study 
SokdnAmut2
brev 
ATCGGAGAACATGTGGGCGTTATC This study 
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at 37 °C in LB medium (10 g/liter Bacto-tryptone, 5 g/liter yeast extract, 10 
g/liter NaCl).  Cultures of S. oneidensis were also grown aerobically with 
shaking (250 rpm) at 30 °C in LB medium. When necessary ampicillin (100 
µg/ml) was added to the media. 
DNA Methods. Standard recombinant DNA methods were used for 
nucleic acid preparation and analysis.20  Genomic DNA was prepared from S. 
oneidensis MR-1 (ATCC 700550) using a Qiagen DNeasy Blood and Tissue kit 
as suggested by the manufacturer. To clone waaA from S. oneidensis MR-1 
into pET16b the primers SowaaAfor/SowaaArev were used to amplify the 
waaA gene from genomic DNA.  To clone EcKdsB and SoKdsB into pET19b 
EcKdsBfor/EcKdsBRev or SoKdsBfor/SoKdsBrev respectively were used to 
amplify the corresponding kdsB gene from genomic DNA.  The purified 
amplified gene products were digested with NdeI and BamHI and were 
ligated into similarly digested pET19b and transformed into E. coli TOP10.  
Isolated plasmid was verified to be correct by sequencing.   
To generate Kd8N in large quantities we adopted a method based on 
that of Camci-Unal et al.21 wherein genes involved in Kd8N synthesis were 
added step-wise.  This strategy allows for genes to be placed into the 
plasmid sequentially using compatible cohesive ends (namely XbaI and 
AvrII) with a ribosomal binding site preceding each gene.  Using site-
directed mutagenesis with the primers AvrIIfor/AvrIIrev, an AvrII restriction 
site was introduced between the BamHI and EcoRI restriction site in the 
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multiple cloning site of pET21b.  This new plasmid, pK8N-1, was transformed 
into E. coli TOP10, isolated, and verified by sequencing.  The genes kdsD 
(So_3856), kdsA (So_3827), kdsC (So_3957), kdnA (So_2476), and kdnB 
(So_2477) were PCR amplified from genomic DNA using the primer 
combinations kdsDfor/kdsDrev, kdsAfor/kdsArev, kdsCfor/kdsCrev, 
kdnAfor/kdnArev, and kdnBfor/kdnBrev respectively and TOPO cloned into 
pCR2.1-TOPO.  The kdsC gene fragment was generated with a silent point 
mutation changing the stop codon from TGA to TAA in order to remove an 
internal NdeI restriction site. The kdnA gene contained two internal NdeI 
sites, which were removed using the central overlapping primer (COP) site 
directed mutagenesis protocol22 as described by Wang et al. to yield pCR2.1-
kdnA-NdeIX using the primers 
SokdnAmut1for/SokdnAmut1arev/SokdnAmut1brev for the first mutation 
and SokdnAmut2for/SokdnAmut2arev/SokdnAmut2brev for the second 
mutation.  The kdsD, kdsA, kdsC, kdnB, and kdnA containing pCR2.1-TOPO 
plasmids were then digested with NdeI and BamHI and the gene fragments 
were purified and ligated into similarly digested pK8N-1 generating pK8N-2, 
pK8N-3, pK8N-4, pK8N-5, and pK8N-6, respectively. 
To generate pK8N-7, pK8N-2 was digested with AvrII and HindIII, 
while pK8N-3 was digested with XbaI and HindIII. Ligation of digested pK8N-
2 with the insert, containing kdsA, from pK8N-3 yielded pK8N-7. pK8N-7 
was then carried forward and this method was used to generate pK8N-8 and 
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pK8N-9, from the carried forward plasmid along with pK8N-4 and pK8N-5, 
respectively. The kdnA gene (pK8N-6) contains an internal HindIII site. Our 
cloning system allows for genes to be cloned in by digestion of the growing 
plasmid (pK8N-9) with AvrII and digestion of pK8N-6 with XbaI and AvrII, as 
XbaI and AvrII form compatible cohesive ends. Ligation of the insert into the 
plasmid destroys the upstream AvrII site, while maintaining the downstream 
AvrII site for further gene insertions. This method can be used in the 
generation of pK8N-10. 
A synthetic construct, pUC57-SoK8N (complete sequence of insert 
given in Appendix C) was designed and purchased from Genscript in their 
CloneEZ method with E. coli codon optimization and the removal of internal 
restriction sites by silent mutation.   
KdsB purification. Decahistidine-tagged EcKdsB and SoKdsB were 
similarly overexpressed in BL21(DE3) cells from pET19b overnight at 17 oC.  
The cells resuspended in 50 mM Tris pH 8.0, 500 mM NaCl and were then 
lysed by sonication.  The enzymes were purified in a single step purification 
by Ni2+ affinity chromatography with a 5 mL Ni-IMAC HisTrap FF column (GE 
Healthcare) with washing consisting of resuspension buffer with 50 mM 
imidazole and elution with 500 mM imidazole.  The proteins were purified to 
>95% purity as judged by SDS-PAGE analysis.  The proteins were dialyzed 
against 10 mM Tris pH 8.0 with final protein concentrations determined by 
58 
 
Bradford assay with bovine serum albumin as a standard.  Protein samples 
were stored at -80 oC. 
KdsB assay. The activity of EcKdsB and SoKdsB was determined 
using the continuous EnzChek pyrophosphate assay kit (Invitrogen) as 
reported previously.11  In brief, 200 µL reaction mixtures containing the 
appropriate enzymes and substrates for the EnzChek kit as specified by the 
manufacturer and the KdsB substrates, 100 mM CTP, and between 25-1000 
µM Kdo analog, either Kdo (Sigma), Kd8N (synthesized by Vahlteich 
Medicinal Chemistry Core, University of Michigan), or Kd8Z (synthesized by 
Vahlteich Medicinal Chemistry Core, University of Michigan) were initiated by 
the addition of 20 nM EcKdsB or SoKdsB in 10 mM Tris pH 8.0, 5 mM MgCl2 
and incubated at 37 oC in 96-well plates in triplicate with appropriate 
controls.  Initial rates were measured at 360 nm for 10 min. 
LPS production and purification. KPM56 cells containing pET16b 
(EV) or pET16b-SoWaaA, S. oneidensis MR-1 and S. oneidensis ΔkdnA 
ΔkdnB12 (a generous gift from Pei Zhou) were grown and prepared as 
described in Chapter II. LPS samples were purified by a modified version of 
the phenol-chloroform-petroleum ether procedure23 as reported previously.24 
Samples were resuspended into LPS-free water (Braun water) to a 
concentration of 1 mg/mL for mass spectrometry analysis. 
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Electrospray-Ionization Fourier-transformed Ion Cyclotron 
Mass Spectrometry. LPS samples were analyzed by mass spectrometry as 
described in Chapter II. 
Kd8Z incorporation and Microscopy.  The E. coli cell line KPM56 
which is capable of surviving without core oligosaccharide in the LPS due to 
lack of WaaA or WaaC was transformed with pET16b or pET16b-SoWaaA.  
Cells were grown with or without the presence of 4 mM Kd8Z, treated, and 




Generation of Kd8N from in vivo expression.  Initial plasmids 
containing the S. oneidensis Kd8N biosynthetic genes were successfully 
generated and added iteratively by the method of Camci-Unal et al.21 as 
described excluding the addition of the kdnA gene fragment.  Each clone 
generated upon addition of the kdnA fragment contained a mutation in said 
gene.  After many attempts, it was decided to purchase a preconstructed E. 
coli codon optimized gene construct constructed similarly to what would 
have been produced by the Camci-Unal method (see Appendix C for 
sequence).  Transformants of the constructed plasmid were successful in E. 
coli TOP10 cells and the plasmid could be propagated and purified by Qiagen 
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miniprep.  Attempts to transform the pUC57-SoK8N plasmid into E. coli 
BL21(DE3) for overexpression and Kd8N production were wholly 
unsuccessful, and we were unable to generate any Kd8N by in vivo 
expression of these genes in our E. coli system.  This is likely due to toxicity 
from overproduction of Kd8N in E. coli cells either through depletion of Kdo 
or NAD+ or glutamate used in the production of Kd8N. 
KdsB substrate selectivity.  Using the enzyme-coupled Enzchek 
pyrophosphate kit, it is possible to measure continuous enzyme activity of E. 
coli KdsB.11  With this method pyrophosphate generated during the reaction 
of Kdo and CTP is cleaved by inorganic pyrophosphatase.  The resulting 
phosphate is used by purine nucleoside phosphorylase to cleave the 
guanosine analog 2-amino-6-mercapto-7-methylpurine ribonucleoside giving 
a signal at 360 nm.  Using this assay, it is possible to similarly test substrate 
analogs of Kdo, namely Kd8N or Kd8Z in this case, as well of other KdsBs.  
This methodology was used in order to probe the substrate specificities of 
EcKdsB and SoKdsB with these substrates.  Each enzyme was tested with a 
range of Kdo analog concentrations at fixed CTP concentration.  The 
dependence of the initial rate on Kdo analog concentration follows Michaelis-
Menten kinetics and is show in Figure 3.5 with calculated kinetic parameters 
in Table 3.2.  These kinetic data show that EcKdsB has strong preference for 
its native substrate Kdo over the other analogs Kd8N or Kd8Z.  Conversely, 




Figure 3.5. Kinetic curves for KdsB and various substrates. Initial rate 
curves upon varying Kdo analog concentration.  Red circles- EcKdsB with 
Kdo, Red triangle- SoKdsB with Kdo, Blue diamond, EcKdsB with Kd8N, Blue 
square- SoKdsB with Kd8N, Green square- EcKdsB with Kd8Z, Green 
triangle- SoKdsB with Kd8Z.  With the exception of the natural substrates 
with their endogenous enzymes most combinations show little to no activity.  
EcKdsB and SoKdsB show highest activities with Kdo and Kd8N respectively. 
 
 
Table 3.2. Kinetic parameters of EcKdsB and SoKdsB with their best 
substrates.  Kinetic values of the best substrate for each EcKdsB with Kdo 
(EcoKdo) and SoKdsB with Kd8N (SonKd8N). 
 
others Kdo or Kd8Z.  Neither EcKdsB nor SoKdsB showed much activity with 
the non-native substrate analogs under the conditions used in this assay 
preventing kinetic parameters from being measured. 
Enzyme and 
substrate 
Km Vmax kcat kcat/Km 
EcoKdo 250 ± 14 μM 1046 ± 21 nM/min 1.74 ± 0.04 s-1 0.00696 μM-1 s-1 
SonKd8N 77.76 ± 2.25 μM 459.9 ± 6.0 nM/min 0.77 ± 0.01 s-1 0.0099 μM-1 s-1 
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Incorporation of azido-Kdo into the LPS of KPM56.  KPM56 is a 
useful tool for the study of Kdo transferases due to its suppressor mutation 
in yhjD, a gene of unknown function.25  Heterologous studies of the 
monofunctional Kdo transferase from A. aeolicus have previously been 
performed19 showing its usefulness for these studies.  A recent click-based 
fluorescence chemistry study showed the ability to label the outer 
membrane of a number of Gram-negative bacteria including E. coli K-12, the 
progenitor of KPM56, with S. oneidensis being the only species attempted 
which could not be labeled.17  Using KPM56, it is possible to determine if the 
Kdo transferase from S. oneidensis is capable of glycosylating Lipid IVA with 
Kd8Z.  Figure 3.5 shows that when KPM56 expressing heterologous SoWaaA 
without Kd8Z is not fluorescently labeled while the same cells when grown 
with 4 mM Kd8Z shows fluorescent labeling demonstrating incorporation of 
Kd8Z into the early core of the LPS. 
Mass spectrometric analysis of isolated LPS samples.  LPS 
samples were generated, purified, and analyzed from the cell line KPM5619 
which is an E. coli cell line lacking the genes waaA or waaC.  Due to the 
absence of these genes waaA non-native Kdo transferases can be studied in 
trans allowing for characterization of these corresponding proteins in an E. 





Figure 3.6. Fluorescent images of Kd8Z incorporation.  Fluorescence 
images of E. coli KPM56 grown without (A) or with (B) the presence of 4 mM 







The lack of the WaaC protein prevents further heptosylation of the 
oligosaccharide which allows for simplification of the LPS analysis.  When 
pET16b (EV) is transformed into the KPM56 and the LPS purified and 
analyzed by mass spectrometry only Lipid IVA (1,4’-bisphosphorylated 
tetraacylated Lipid A, observed mass 1404.861 u, calculated mass 1404.854 
u) and the phosphoethanolamine-modified Lipid IVA (observed mass 
1527.860 u, calculated mass 1527.862 u) is detected.  Upon the addition of 
the pET16b-SoWaaA into KPM 56, The mass spectrum of the LPS shows the 
addition of peaks representing Kdo modification.  Kdo-Lipid IVA appears 
(observed mass 1624.907 u, calculated mass 1624.912 u) as well as the 
same species modified with phosphoethanolamine (observed mass 1747.917 
u, calculated mass 1747.921 u) and then further modified with lauric acid 
(observed mass 1930.087 u, calculated mass 1930.088 u).  The mass 
spectra can be seen in Figure 3.6. 
Additional samples were purified and analyzed from S. oneidensis MR-
1 and S. oneidensis ΔkdnA ΔkdnB.  These samples show a pattern consistent 
with a full-length oligosaccharide core LPS.  For the WT S. oneidensis strain 
the m/z peak of 2908.39 u seems to correspond of unmodified full LPS.  
Unfortunately, the exact mass of these species cannot be calculated as the 
full structure of S. oneidensis is unknown, although the structure of the core 
oligosaccharide has previously been determined.7  The corresponding m/z 
peak for the mutant strain lacking the ability to generate Kd8N is 2909.37 u.  
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Both sets of peaks show Δm/z= ±14.01 u characteristic of longer or shorter 
fatty acid addition on the Lipid A portion of LPS.  Additionally, both sets of 
spectra show the addition of Δm/z= 123 u characteristic of the addition of a 
single phosphoethanolamine adduct and Δm/z=80.07 u characteristic of the 
addition of a phosphate.  These modifications are verification that these 
peaks correspond to those of LPS molecules purified from these cells.  The 
spectra of the full-length LPS samples from S. oneidensis and the mutant 
can be seen in Figure 3.7.   
The difference between the unmodified LPS masses for the WT and 
mutant samples of Δm/z=0.98 u.  This mass difference most likely 
corresponds with a difference of incorporation of a single Kdo moiety into the 
LPS compared to a single Kd8Z.  Kdo has an exact mass of 238.07 u while 
Kd8Z has an exact mass of 237.08 u giving a mass difference of 0.99 u.  
This shows that the mutant strain lacking Kd8Z is able to substitute Kdo into 




Figure 3.7. Mass spectra for incorporation of Kdo by SoWaaA.  Mass 
spectra of the LPS purified from KPM56 containing either pET16b (A) or 
pET16b-SoWaaA (B).  The addition of SoWaaA generates a glycosylated 








Figure 3.8. S. oneidensis and Kd8N knockout full length LPS spectra.  
Mass spectra of the LPS purified S. oneidensis of the ΔkdnA ΔkdnB mutant.  
Typical fatty acid variation pattern of Δm/z=±14.01 u can be seen in the 
samples as well as common LPS modifications.  A Δm/z=0.98 u can be seen 






 Shewanella spp. with the only known exception being S. putrefaciens 
are unique among known Gram-negative bacteria for their ability to 
incorporate Kd8N into the core oligosaccharide of their LPS.  The pathway by 
which S. oneidensis biosynthesizes Kd8N was recently discovered.12  To 
begin understanding the method by which S. oneidensis can selectively 
incorporate Kd8N over Kdo, we attempted to generate a large quantity of 
Kd8N using the method of Camci-Unal et al.21  Unfortunately this proved 
intractable due to the inability of E. coli cell lines tested to grow in the 
presence of the Kd8N biosynthetic genes.  This could be due to unregulated 
overconsumption of NAD+ or glutamate by KdnB or KdnA in the production 
of the amino sugar (see Figure 3.2).  The sugar was instead generated 
synthetically by the Vahlteich Medicinal Chemistry Core for further studies. 
 KdsB from E. coli is well studied both kinetically and structurally11, 26, 
27, while the KdsB from S. oneidensis is poorly characterized.  While these 
proteins show a high amount of conservation (45% identity), it is known 
that SoKdsB is able to activate Kd8N in vivo while EcKdsB is not.12  In order 
to verify this selectivity in vitro as well as to study the substrate preferences 
of SoKdsB, the enzymes were probed by the Enzchek pyrophosphate assay.  
In these assays, it was verified that indeed EcKdsB has a strong preference 
for Kdo over Kd8N as was suggested by the in vivo studies.  Additionally, 
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SoKdsB also seemed to prefer its native substrate of Kd8N over Kdo in our 
reaction conditions.  Both enzymes had virtually no detectable activity for 
Kd8Z under these conditions.  From these enzyme assays it seems that 
SoKdsB could have a large effect in the overall selectivity of S. oneidensis for 
Kd8N over Kdo in the core oligosaccharide. 
 Previous attempts to fluorescently label S. oneidensis through click-
mediated chemistry were unsuccessful.17  The authors of the study stated 
that the inability to incorporate Kd8Z into the LPS was due to Kd8N being 
the native substrate rather than Kdo which prevents the incorporation of 
Kd8Z.  To determine if SoWaaA is capable of incorporating Kd8Z into the LPS 
of an E. coli cell line, KPM56, lacking both waaA and waaC, was used.  Using 
this cell line, we see that SoWaaA seems to be capable of incorporating 
Kd8Z such that the cells can be fluorescently labeled in the presence of the 
azido sugar as visualized by fluorescence microscopy.  This shows that 
SoWaaA is not specific to Kd8N and can incorporate Kdo analogs into LPS.  
Carrying on from this, we tested the ability of SoWaaA to transfer Kdo into 
the core oligosaccharide in KPM56 in the absence of both Kd8N or Kd8Z.  
The mass spectrum of the cell line with the empty vector pET16b shows that 
the cell line alone is incapable of addition of any sugar into the core 
oligosaccharide while expression of the pET16b-SoWaaA allows the 
incorporation of a single Kdo moiety into the LPS.  This shows for the first 
time that SoWaaA is able to act as a monofunctional Kdo transferase in vivo.  
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It seems from these experiments that SoWaaA is capable of accepting a 
range of Kdo analogs for incorporation into LPS and likely has little to do 
with Kd8N selectivity. 
 The genes kdnA and kdnB are now known to be responsible for the 
generation of Kd8N in S. oneidensis.  In their study, Gattis et al. removed 
these genes showing that they are not only dispensable for survival of the 
cell, but also had a marginal effect on susceptibility to polymyxin B or bile 
salts, 3-fold and 2-fold increase respectively.12  One would suspect that if S. 
oneidensis had a strict selectivity for Kd8N over Kdo lack of kdnA and kdnB 
would prevent incorporation of Kd8N into the core oligosaccharide leading to 
complete truncation of the LPS.  While, E. coli cells lacking the core 
oligosaccharide show a 125-fold increase in sensitivity to bile salts compared 
to wild-type;28 the lack of comparatively similar increase in sensitivity led us 
to believe that the LPS of the S. oneidensis lacking Kd8N maintained the 
ability to generate a core oligosaccharide.  We obtained the mutant strain 
and grew, purified, and analyzed the LPS along with that of wild-type S. 
oneidensis.  As expected both samples showed mass peaks characteristic of 
rough type LPS samples.  Indeed, the samples of the mutant LPS varied only 
by a Δm/z of 0.98 u corresponding to a difference of Kd8N vs Kdo.  This 
shows that not only is Kd8N dispensable for the cells, but also that Kdo is 
able to substitute completely for Kd8N in the LPS and able to generate fully 
elaborated core oligosaccharide.  This shows that although SoKdsB has 
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selectivity in vitro, it seems to be able to compensate in vivo to allow for full 
LPS elaboration.  In the end the true selectivity of Kd8N selection over Kdo 
selection may be determined solely by the availability of Kd8N over Kdo.  S. 
putrefaciens CN-32 is the only known species of Shewanella to date which 
does not incorporate Kd8N into its LPS.8  A BLAST search of KdnB or KdnA 
finds no closely related homologs of either in this subspecies of S. 
putrefaciens demonstrating that a native Shewanella species can naturally 
survive without these genes and generate full LPS. 
 Although most studied strains of Shewanella contain Kd8N in their core 
LPS, this unique sugar is not essential for growth or full LPS elaboration in S. 
oneidensis MR-1.  The KdsB of this species in vitro seems to have a 
preference for Kd8N over Kdo, but in the end the overall preference of the 
cell seems to hinge on the presence or absence of KdnA or KdnB in the cell.  
Further studies are needed to fully elucidate the reason for which 
Shewanella typically display Kd8N in their outer membrane rather than Kdo, 
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Summary, conclusions, and future directions 
 
 The focus of this dissertation was on the study of variability in the 
early core oligosaccharide in Gram-negative bacteria.  A cell line was 
constructed which not only lacked the ability to biosynthesize a 
lipopolysaccharide (LPS) core natively but was shown to also be able to 
generate unnatural early core structures by expressing exogenous genes.  
Additionally, we explored the selectivity of the species Shewanella 
oneidensis in the incorporation of the unique sugar 8-amino-3,8-dideoxy-D-
manno-octulosonic acid (Kd8N). 
 LPS is an interesting, yet highly complex glycolipid which is found in 
nearly all Gram-negative bacteria.  The presence of LPS is essential to the 
bacteria for their survival and well-being but plays a large role in bacterial 
pathogenesis.  Since the discovery of the endotoxic properties of LPS vast 
amounts of research and study have gone into how to alleviate its 
detrimental properties while simultaneously trying to develop it for the use 
as an antigen for vaccine therapies.  Unfortunately, throughout all of these 
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previous studies, the ability to generate analogs of LPS has been limited to 
single knockouts and complex multi-step synthetic production.   
 With the creation of the WOD02 cell line, it is now possible to obtain 
core oligosaccharide LPS modifications in a straightforward and simple 
fashion.  This cell line represents a tool which can be carried forward to not 
only further generate complete LPS core, but also study biosynthetic 
properties of glycosyltransferases and other LPS modifying enzymes that 
would have been extremely difficult otherwise. To date, many cell lines have 
been created to generate and study truncated LPS glycolipids, but all of 
these cell lines have had drawbacks either in very slow growth rates, lack of 
ability to generate necessary carbohydrates, requiring supplementation for 
growth, containing enzymes which complicate proper glycoform production, 
or are unable to generate non-native glycoforms.  The generation of the 
WOD02 cell line is the first cell line to fully circumvent all of these drawbacks 
giving a viable cell line with a blank canvas for complete generation and 
study of LPS and LPS biosynthesis. The availability of such a tool could allow 
for faster development of non-toxic LPS based vaccines.1  This cell line 
represents a step forward in our ability to quickly and easily generate 
glycoforms essential for research and medicinal usage. 
Many questions remain in the realm of LPS biosynthesis.  While the 
biosynthesis of the Lipid A region has largely been elucidated,2 the 
biosynthesis of the oligosaccharide core remains mostly unknown. Utilizing 
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the WOD02 system we have generated, it is now possible as we have shown 
to create novel glycolipids.  This cell line has the potential to be used in 
order to elucidate the LPS structures of many Gram-negative bacteria which 
are not directly amenable to growth in laboratories.  By inserting the core 
oligosaccharide biosynthetic genes we could generate a fully elaborated 
glycolipid in a clean E. coli background system giving use useful information 
on the properties of the outer membrane of a vast number of Gram-negative 
bacteria.  Additionally, the use of this cell line allows us to generate various 
substrates in order to study enzyme function and selectivity.  Studying the 
selectivity of glycosyltransferases involved in LPS core biosynthesis has been 
to date a complex undertaking.  In order to study these enzymes in vitro, 
one would need to biosynthesize a complex amphipathic glycolipid through a 
multistep process.  Truncated native glycolipids could be generated for in 
vivo studies, but this would require removing genomic copies of genes in the 
species of choice which could be quite complicated.  On the other hand, with 
the creation of the WOD02 cell line, it is now possible to biosynthesize your 
substrate of choice simply by expressing the desired genes to generate the 
glycolipid which could be used for in vivo studies or further purified for in 
vitro studies.  The ability to simply generate these substrates greatly opens 
the door for understanding the biosynthesis and selectivity of these late 
glycosyltransferases which to date have been nearly impossible to properly 
characterize. The exact function of even some of the core modifying genes 
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within E. coli is not yet fully understood, and only recently with gene 
expression studies are we beginning to see a connected effect between LPS 
glycoform and gene regulation.3  Studies with the WOD02 cell line are 
allowing us to understand through gene expression studies the effects of LPS 
modifications on the bacteria themselves which often lead to increased 
stress responses from LPS truncations.  Having a cell line lacking all core 
sugars opens many doors to studies which could not have been 
accomplished otherwise. 
 However, other more unique modifications of core LPS exist as well 
though which are less directly amenable to the WOD02.  In these cases, 
such as for Kd8N, the organisms in question must be probed.  Kd8N exists 
as one of two rare, alternate Kdo analogs seen in Gram-negative bacteria.  
The reason that such a sugar is used in these particular Gram-negative 
bacteria is still unknown, but we have advanced our understanding of the 
pathway by which Kd8N is biosynthesized4 and gained insight into how this 
sugar is selected over Kdo.  Further studies are needed to elucidate the 
effects Kd8N might have on endotoxicity of the LPS upon incorporation, and 
what function this unique sugar has for these bacteria.  By now 
understanding how the Kd8N is selected in S. oneidensis, it could now to 
possible to combine this selectivity together with the blank canvas generated 
from WOD02 to create even more unique LPS core glycoforms.  This would 
further push our understanding of outer membrane stability in Gram-
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negative bacteria and give us an additional route to create new LPS analogs 
for vaccine and adjuvant studies.   
 It is my hope that this technology will be carried on and help us to 
overcome many of the hurdles we currently have in generating vaccine 
therapies of LPS against a number of deadly infectious bacteria.  With this 
technology the rapid generation of analogs is now a distinct possibility and 
should allow us to bring these ever important lifesaving therapies to fruition.  
This technology opens us up to many new unexplored possibilities that I 
believe will be a great stepping stone to our full understanding of LPS core 
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Family I inorganic pyrophosphatases (PPiases) are ubiquitous enzymes 
that are critical for phosphate metabolism in all domains of life. The detailed 
catalytic mechanism of these enzymes, including the identity of the general 
base, is not fully understood. We determined a series of crystal structures of 
the PPiase from Mycobacterium tuberculosis (Mtb PPiase) bound to catalytic 
metals, inorganic pyrophosphate (PPi; the reaction substrate) and to one or 
two inorganic phosphate ions (Pi; the reaction product), ranging in resolution 
from 1.85 to 3.30Å. These structures represent a set of major kinetic 
intermediates in the catalytic turnover pathway for this enzyme and suggest 
an order of association and dissociation of the divalent metals, the substrate 
and the two products during the catalytic turnover. The active site of Mtb 
PPiase exhibits significant structural differences from the well characterized 
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Escherichia coli PPiase in the vicinity of the bound PPi substrate. Prompted 
by these differences, quantum mechanics/molecular mechanics (QM/MM) 
analysis yielded an atomic description of the hydrolysis step for Mtb PPiase 
and, unexpectedly, indicated that Asp89, rather than Asp54 that was 
proposed for E. coli PPiase, can abstract a proton from a water molecule to 
activate it for a nucleophilic attack on the PPi substrate. Mutagenesis studies 
of the key Asp residues of Mtb PPiase supported this mechanism. This 
combination of structural and computational analyses clarifies our 
understanding of the mechanism of family I PPiases and has potential utility 




Inorganic pyrophosphate (PPi) is produced during the metabolism of 
various biologically important molecules such as proteins, nucleic acids, and 
fatty acids.1 The hydrolysis of PPi into two molecules of inorganic phosphate 
(Pi) in the cytoplasm is catalyzed by inorganic pyrophosphatase (PPiase). 
This enzymatic degradation of PPi alleviates inhibitory effects of PPi on PPi-
generating reactions and drives them thermodynamically.2, 3 Inorganic 
pyrophosphatase displays significant catalysis in the reverse direction, to 
form PPi, with a rate constant for the PPi synthesis step only 5-fold smaller 
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than that for the hydrolysis step for Escherichia coli inorganic 
pyrophosphatase.4 Inorganic pyrophosphatases are divided into four 
families: families I, II and III of cytoplasmic pyrophosphatases and a family 
of integral membrane H+/Na+-dependent inorganic pyrophosphatases. 
Family I PPiases are ubiquitous and present in most eukaryotes, archaea and 
bacteria, family II enzymes are found only in some bacteria, archaea and 
primitive eukaryotes and family III PPiases are relatively unexplored 
enzymes found in a few bacterial species.5-9 A small number of bacteria 
including Vibrio cholerae contain both family I and family II PPiases.10 Even 
though PPiases from families I and II are not homologous to each other in 
sequence or overall structure, they employ similar divalent metal-dependent 
catalysis; family III appear to be modified haloalkane dehalogenases, which 
function by a distinct mechanism. The catalytic mechanism and the spatial 
arrangement of the catalytic residues in PPiase families I and II are thought 
to have emerged through convergent evolution.8 For family I PPiases, a 
mechanism was proposed in which the PPi substrate is activated for 
hydrolysis by three separate divalent metal ions in the enzyme catalytic site 
(Figure A.1).11 Two of these ions (M1 and M2) are thought to be involved not 
only in positioning and activating the substrate, but also in increasing the 
third divalent ion (M3) coordinates the PPi and active site residues, thereby 





Figure A.1. Previously proposed PPiase mechanism. A catalytic 
mechanism proposed previously for family I PPiases. The active site already 
containing the catalytic water (Wc) and divalent metal ion M2 (i) captures the 
PPi substrate along with divalent metal ions M1 and M3 (ii). The nucleophilic 
hydroxide formed via proton abstraction by an Asp residue (Asp67 in E. coli 
PPiase, Asp54 in Mtb PPiase) attacks the activated electrophilic phosphate 
group of the PPi (iii). Upon hydrolysis (iv), a new catalytic water rebinds and 
the other phosphate group dissociates, yielding complex (v), which then 
releases the attacked Pi. 
 
nucleophilicity of a putative water molecule, Wc for the attack on the PPi. The  
divalent metals, the PPi substrate is stabilized by intermolecular salt bridges 
and hydrogen bonds with protein residues. The catalytic water is thought to 
be activated both by the bridging metal ions and, through proton 
abstraction, by one of the nearby aspartate residues (Asp67 in E. coli 
PPiase11 which corresponds to Asp54 in Mtb PPiase), resulting in conversion 
of the water into a nucleophilic hydroxide, which then hydrolyzes the 
phosphodiester bond linking the two phosphate groups of the PPi. The 
central role of the catalytic water in the mechanism was postulated based on 
site-directed mutagenesis studies with E. coli PPiase,12 and the location of 
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this water was inferred to coincide with that of an inhibitory fluoride ion 
observed in crystal structures of E. coli and Saccharomyces cerevisiae 
PPiases in complex with PPi.11, 13 Asp67 of E. coli PPiase as the catalytic base 
was proposed based on the direct interaction of this residue with the fluoride 
ion observed in the crystal structure of E. coli PPiase in complex with PPi, 
fluoride and Mg2+ (Protein Data Bank accession code: 2AUU). 
Despite this proposed role of Asp67 of E. coli PPiase, mutations of this 
residue to a Glu resulted in a modest 5-fold loss in kcat with a compensatory 
5-fold gain in affinity.12 In contrast, mutating other metal ion coordinating 
active site Asp residues in the same study had a more pronounced effect: a 
mutation of Asp70 (Asp57 in Mtb PPiase) to a Glu decreased kcat more than 
2000-fold, a mutation of Asp102 (Asp89 in Mtb PPiase) decreased kcat ∼7-
fold. Another study probed the function of these Asp residues by mutating 
them to a less sterically perturbing Asn. For Asp67Asn, Asp70Asn and 
Asp102Asn, the effect was a ∼26-fold, a 150-fold and a 90-fold decrease in 
kcat, respectively.14 Such modest effects of mutating Asp67 and comparable 
effects of other mutations suggest that there are back-up water activation 
mechanisms, which involve other Asp residues. Moreover, due to the 
involvement of Asp residues in the network of divalent metal coordination, 
which is critical to both substrate binding and catalysis, mutations of these 
residues perturb this coordination, complicating interpretation of the 
mechanistic role of these residues in catalysis. Therefore, the mutagenesis 
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studies leave the precise mechanism of the water activation unresolved, 
whereas structural studies alone are indirect. 
E. coli,15 Mycobacterium tuberculosis (Mtb),16 as well as S. cerevisiae17 
contain family I PPiases, and these enzymes are essential for survival of 
these organisms. Because of the global clinical significance of Mtb as a 
deadly pathogen, Mtb PPiase is considered to be a potential target for novel 
anti-tuberculosis drugs.18, 19 In addition to extensive structural and 
biochemical studies on E. coli and S. cerevisiae PPiases,8, 11, 13, 20-22 X-ray 
crystallographic studies were also carried out with the Mtb PPiase,23, 24 
providing structural information on the location of a sole phosphate ion in 
the active site (PDB ID: 1WCF). The position of this Pi, presumably 
mimicking the second Pi product to dissociate, agrees with a position of the 
sulfate ion bound to the E. coli PPiase (PDB ID: 1JFD25). On the other hand, 
the opposite order of dissociation of the two Pi products (Figure A.1) was 
proposed based on another crystal structure of E. coli PPiase, obtained by 
soaking inhibitory fluoride out of the crystals of the complex of this enzyme 
with PPi and fluoride (PDB ID: 2AU811). Therefore, the order of product 
dissociation events in the catalytic turnover of bacterial PPiases remains to 
be clarified. In addition, the active site of Mtb PPiase displays unique 
features,23, 24 such as two His residues that are not present in E. coli and 
whose role in catalysis is not clear. These His residues appear to be too far 
to interact with the substrate directly, but they can help orient the residues 
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that are directly involved in catalysis. A double mutant of the His residues 
reduced kcat 5-fold, demonstrating a modest effect.24 
In this study, we focused on obtaining more complete structural 
information on Mtb PPiase, to elucidate mechanistic details for Mtb PPiase 
and clarify our understanding of bacterial PPiases in general. We determined 
a set of crystal structures of Mtb PPiase bound to divalent metal ions and in 
complexes with its catalytic substrate, PPi, and product, Pi. These structures 
have been employed to investigate details of the hydrolysis step catalyzed 




Protein mutagenesis and purification. Mutations Asp54Asn, 
Asp57Asn and Asp89Asn were introduced by using vector pJexpress411-
mtPPiase encoding a hexahistidine-tagged Mtb PPiase (a gift of Dr. Luiz 
Pedro de Carvalho) as a template and performing PCR with overlapping 
mutagenic primers by using Phusion DNA polymerase (New England 
Biolabs). The primer pairs were as follows: 5′-GGTGACGATGGCAACCCGCTG 
GACG-3′ and 5′-CGTCCAGCGGGTTGCCATCGTCACC-3′ for D54N, 5′-GCG 
ACCCGCTGAACGCGCTGGTG-3′ and 5′-CACCAGCGCGTTCAGCGGGTCGC-3′, 
for D57N, 5′-CACGGCGGCAACGACAAAGTGCTGTGC-3′ and 5′-GCACAGC 
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ACTTTGTCGTTGCCGCCGTG-3′ for D89N. The PCR reaction was followed by 
digestion with DpnI according to the QuikChange kit protocol (Agilent 
Technologies), and a transformation into chemically competent TOP10 cells 
(Life Technologies). All DNA sequences were verified by DNA sequencing 
(Eurofins Genomics). 
Hexahistidine-tagged wild-type Mtb PPiase and its mutants Asp54Asn, 
Asp57Asn and Asp89Asn were expressed and purified by Ni2+ affinity 
chromatography with a 5 mL Ni-IMAC HisTrap FF column (GE Healthcare), as 
described previously.18 The proteins were then dialyzed against dialysis 
buffer (40 mM Tris HCl pH 8.0, 100 mM NaCl and 2 mM β-mercaptoethanol). 
These analogously purified proteins were used for the activity assays. For 
crystallization, the wild-type protein was further purified on a size exclusion 
S-200 column (GE Healthcare) equilibrated in gel filtration buffer (40 mM 
Tris HCl pH 8.0, 100 mM NaCl). Fractions containing Mtb PPiase were pooled 
and concentrated using an Amicon Ultra-15 centrifugal filter device 
(Millipore) to 750 μM and stored at 4 °C. 
Pyrophosphatase activity assay. The measurements of PPi 
hydrolytic activity of Mtb PPiase and its mutants by following a protocol that 
we recently reported,6, 18 with minor modifications, as described below in 
brief. All reactions were carried out in 20 mM Tris HCl pH 7.5 and 1 mM 
MgCl2. The reactions were stopped after 10 min by adding 150 μL of the 
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malachite green reagent to a 30 μL reaction. After 2 min, 15 μL of 34% 
sodium citrate was added for color stability. The color was allowed to 
develop for 30 min, then the mixture was transferred to a 96-well clear flat-
bottom plate and the absorbance at 620 nm was measured with a 
SpectraMax M5 plate reader. We first established that 2 nM of the wild-type 
Mtb PPiase and Mtb PPiase Asp54Asn was an appropriate concentration for a 
steady-state kinetic measurement of reaction rate (V) with 200 μM PPi, as 
this concentration corresponded to the linear range of product accumulation 
over time. The majority of substrate under these conditions was not 
hydrolyzed. Similarly, 800 nM of the weakly active mutants Asp57Asn and 
Asp89Asn yielded steady-state measurements for a 10 min reaction. We 
then used these enzyme concentrations and the 10 min reaction time to 
perform measurements of absorbance as a function of PPi concentration, as 
specified in the text. All reactions were performed in triplicate. 
The values of steady-state kinetic parameters Km and Vmax,app were 
obtained by non-linear regression analysis of absorbances (A) as a function 
of [PPi] by using SigmaPlot (SysStat) with the Michaelis–Menten equation 
A=A0+Vmax,app[PPi]/(Km+[PPi]), where A0 is the absorbance in the absence of 
PPi. The values of kcat were obtained by dividing Vmax,app by the enzyme 
concentration, reaction time and the unit conversion constant from 
absorbance units to M of PPi hydrolyzed. The last constant was determined 
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by calibration measurements of absorbance with increasing concentrations of 
Pi in the reaction buffer, without enzyme and PPi. 
Crystallization and crystal cryoprotection. All complexes were 
crystallized by vapor diffusion in hanging drops at 22°C. The drops contained 
a mixture of 1μL of the reservoir solution and 1μL of concentrated protein 
(∼14mg/mL) equilibrated against the reservoir solution. The crystals of Mtb 
PPiase in complex with PPi were obtained with the reservoir solution 
composed of 1.65M NaKHPO4, 100mM HEPES pH 7.75 and 2mM CaCl2, the 
crystals of Mtb PPiase in complex with two Pi ions were obtained with the 
reservoir solution composed of 1.6M KH2PO4, 100mM HEPES pH 7.75 and 
2 mM CaCl2, and the crystals of Mtb PPiase in complex with one Pi were 
obtained with the reservoir solution containing 1.57M NaKHPO4, 100mM 
HEPES pH 7.75 and 2mM MnCl2. In order to obtain crystals of Mtb PPiase 
bound to different divalent metal ions, we first grew crystals by using 
reservoir solution containing 9% PEG 4000, 100mM HEPES pH 7.0 and 
100mM CaCl2 and then soaked these crystals with the reservoir solution, in 
which Ca2+ was substituted with Mg2+ or other divalent metal ions. Single 
crystals were obtained in each condition in 1–5 days. Crystals were gradually 
transferred over 30 min from their mother liquors to the reservoir solutions 




Data collection, and structure determination. X-ray diffraction 
data for crystals of Mtb PPiase–PPi and Mtb PPiase–2Pi complexes were 
collected at beamline 22-ID-D and all the other data were collected at 
beamline 21-ID-F of the Advanced Photon Source of the Argonne National 
Laboratory at 100 K and processed using program HKL2000.26 The structure 
of Mtb PPiase bound to Mg2+ was determined by molecular replacement by 
using the previously reported structure of apo-Mtb PPiase (PDB ID: 1WCF23) 
as a search model, with program Phaser.27 The other structures were 
determined by molecular replacement with the structure of the Mtb PPiase–
Mg2+ complex as a search model. The structures were refined and rebuilt 
iteratively by using programs REFMAC28 and COOT,29 respectively. The data 
collection and refinement statistics are provided in Table A.1. The crystal 
structure coordinates and structure factors were deposited in the Protein 
Data Bank with the PDB accession numbers: 4Z70, 4Z71, 4Z72, 4Z73, 4Z74, 
as specified in Table A.1. 
QM/MM simulations. The crystal structure of Mtb PPiase bound to PPi 
was used for all simulations. For all the QM/MM simulations one hexamer of 
Mtb PPiase was considered. One of the six active sites of the hexamer was 
treated as a QM subsystem, starting from the experimentally defined 
locations of the substrate, cations and side chains. The Ca2+ ions in the 












PDB ID 4Z74 4Z72 4Z73 4Z70 4Z71 
Space group P212121 P6322 P212121 P3221 P3221 
Monomers (a.u.) 12 1 12 3 3 
Unit cell 
dimensions: 
a,b,c (Å)  
α, β, γ (°) 
87.0, 105.2, 
255.9 
90, 90, 90 
99.3, 99.3, 
96.7 
90, 90, 120 
85.6, 105.1, 
254.7 
90, 90, 90 
102.1, 102.1, 
80.4 
90, 90, 120 
101.7, 101.7, 
81.2 












Rmerge (%) 8.8 (57.9) 12.0 (78.3) 15.7 (54.2) 6.7 (52.6) 7.4 (57.9) 




(100.0) 99.3 (98.9) 100.0 (100.0) 100.0 (100.0) 100.0 (100.0) 
Redundancy 7.5 (7.6) 7.1 (7.4) 6.9 (7.0) 12.4 (12.5) 11.1 (11.1) 














reflections 73,541 11,538 33,599 33,886 39,587 
R (%) 20.8 (28.4) 20.8 (29.8) 21.9 (28.9) 20.9 (25.2) 17.4 (20.0) 
Rfree (%) 24.9 (34.8) 24.1 (31.1) 25.9 (32.9) 25.4 (27.6) 20.8 (24.0) 
Number of 
atoms/a.u. 16,428 1321 15,551 4627 4500 
r.m.s. deviations: 
Bond length (Å) 
































a Values in parentheses refer to the highest resolution shell 
b PROCHECK output 
Table A.1. Crystallographic data of MtbPPiase. Data collection and 
refinement statistics 
 
using MolProbity30, 31 and electro-neutralized by adding 51 K+ ions using the 
tleap program of AMBER12 package32. The subsequent MD simulations with 
this neutralized system were unstable, as characterized by large fluctuations 
of density and energies. Therefore, we instead both neutralized the system 
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and increased its ionic strength to 100 mM by adding 102 K+ ions and 51 Cl− 
ions using tleap function in AMBER12. The system was solvated with TIP3P 
water33 with a 15 Å buffer in a final box size of approximately 150 Å×140 
Å×147 Å. The total number of atoms in the system used in the MD 
simulations was 50,396. 
The MD simulations were performed using the PMEMD program in the 
AMBER12 software suite with the ff99SB force field.34 The SHAKE algorithm 
was applied for bonds between heavy atoms and hydrogen.35 All MD 
simulations were carried out under periodic boundary conditions by the 
smooth particle mesh Ewald (sPME) method for long-range electrostatic 
interactions.36, 37 Systems were minimized using sander function with 50 
steps of steepest descent and 450 steps of conjugate gradient with a 
restraint of 500 kcal mol−1 Å−2 on the protein atoms. Densities of the 
systems were equilibrated to 1 g cm−3 in the NPT ensemble with pressure 
being held constant by anisotropic pressure scaling. The systems were 
gradually heated to 300 K under constant volume conditions with 500 kcal 
mol−1 Å−2 restraints on the protein atoms that were gradually removed. 
Temperature was kept constant by using the Langevin thermostat.38 Non-
restrained production MD was performed for 20 ns for each system with 
snapshots saved at each 1 ps. Twenty random snapshots were selected from 
the MD trajectory and the PPiase active sites were observed for waters that 
could be considered as possible candidates to carry out a nucleophilic attack 
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on the PPi. The selection criteria for a candidate water included the distance 
between the oxygen atom of the candidate water and the closer phosphorus 
atom of the PPi as well as the angle of attack formed by these two atoms 
and the bridging oxygen of the PPi. Upon selection of such a water, ten 
snapshots for which the angle of the attack was closest to 180° were 
selected from the trajectory for QM/MM calculations. 
All atoms in the PPiase hexamer, and water molecules that were within 
48 Å of the attacked phosphorus atom of PPi in the selected active site, were 
considered in the QM/MM calculations. The QM subsystem was chosen to 
include the side-chains of Asp57, Asp84 and Asp89, PPi, three Mg2+ ions that 
correspond to M1, M2, M3, and 13 water molecules including the attacking 
water. All atoms where a covalent bond crosses the QM/MM boundary were 
treated using the pseudobond approach,39, 40 yielding a smooth connection at 
the QM/MM interface. All the QM/MM calculations were performed by means 
of an in-house program that links modified versions of Gaussian0941  and 
TINKER42 to perform additive QM/MM with electrostatic embedding. An 
iterative method was used in the QM/MM optimizations and were performed 
at the B3LYP/631G(d,p) level of theory.43 
The reaction path was calculated by using the quadratic string method 
(QSM).44 The path was created using 18 images, including the optimized 
reactant and the product structures at each end. The MM subsystem of the 
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optimized reactant was used as the starting MM subsystem for each of the 
intermediate structures between the optimized reactant and the product. 
These starting MM subsystems of the 16 intermediates were then subjected 
to constrained optimization.45 The constraints were gradually reduced after 
each QM/MM optimization cycle. As before, the individual QM/MM 
optimizations for each of the 16 structures were performed using the same 
in-house program that links modified versions of Gaussian09 and TINKER. 
The structure corresponding to the highest energy point in the optimized 
path calculated using QSM was used as the starting structure for the 
transition state optimization. Transition state optimization was performed 
using the QST3 method. No negative frequencies were present in any 
minima and the TS exhibited only one imaginary frequency corresponding to 




Structures of Mtb PPiase in complex with PPi and with two Pi 
ions. A structure of Mtb PPiase–PPi complex was determined at the 
resolution of 2.55 Å from crystals of Mtb PPiase grown at high concentration 
of sodium/potassium HPO42− salt in the presence of Ca2+ (Figure A.2). In this 
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crystal form, there were two Mtb PPiase hexamers per asymmetric unit. 
Surprisingly, a PPi molecule, instead of the expected Pi, was bound to all 12  
 
Figure A.2. Mtb PPiase-PPi structure.  A cartoon view of an Mtb PPiase 
hexamer from the crystal structure of Mtb PPiase–PPi complex. The six 
monomers are colored differently, and the bound PPi molecules are shown by 
orange sticks. The representative monomer colored gray is shown in 
subsequent figures in a similar orientation. 
 
active sites in the two Mtb PPiase hexamers (Figure A.3A). The PPi was 
generated from two molecules of Pi by the reaction catalyzed by Mtb PPiase 
in the direction of synthesis, driven by a high Pi concentration. The location 
and the conformation of the PPi in all 12 active sites were nearly identical, 
whereas the location and the occupancy of a Ca2+ at position M1 (most 
commonly coordinating both Asp57 and Asp89) as well as the conformation 
of the side chain of Asp89 and, to a lesser extent of Asp57, were somewhat 
variable among the different active sites. Several stably bound water 
molecules were well resolved in all active sites in the vicinity of Asp57, 
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Asp89 and the PPi. In some active sites, water molecules were found to be 
directly coordinated to M1 or M2 but not to both ions at the same time. Such  
 
Figure A.3. Mtb PPiase active sight with substrate or product bound. 
The active site of Mtb PPiase in the structures of its complexes with PPi, 2Pi 
and Ca2+. (A) The complex of Mtb PPiase with PPi. The mesh represents an 
omit Fo–Fc electron density map contoured at 3.0σ that was generated by 
using a model devoid of the PPi, metal ions M1, M2 and M3 and the water 
molecules (discussed in the text). (B) The complex of Mtb PPiase with 2Pi. 
The mesh represents an omit Fo–Fc electron density map contoured at 4.0σ, 
generated without the two Pi, metal ion M2 and the water molecule. The 
second Ca2+ ion (labeled Mx) coordinated to Glu18 and two water molecules 
was observed in this structure at a site unrelated to M1, M2 or M3. In both 
panels, the residues that interact with the substrate, products (orange 
sticks) or metal ions (green spheres) are shown as cyan sticks. Water 
molecules are shown as red spheres. 
 
bidentate coordination or even hydrogen bonding by a water molecule would 
not be possible due to geometrical constraints (M1–M2 distance of 6.4 Å, with 
the intervening side chain of Asp57). An example of an active site (which 
belongs to monomer A in the coordinate file; PDB ID: 4Z74) is shown in 
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Figure A.3A, where a water molecule (W1) forms hydrogen bonds with 
Asp57, an adjacent phosphate group of the PPi and with other water 
molecules coordinated to M1 and M2 ions. This water molecule superposes 
nearly  
perfectly with the location predicted to be occupied by the catalytic 
hydroxide ion in structure-based mechanistic studies of E. coli PPiase, i.e., 
matching the site of a fluoride and a water in the respective structures of E. 
coli PPiase structures with bound PPi (PDB IDs: 2AUU and 1I6T)11 (Figures 
A.1 and A.4C). Another water molecule (designated as W2 in Figure A.3A) 
was observed coordinated to metal ion M3, at a hydrogen bonding distance 
from the PPi and in the vicinity of Asp89. 
When KH2PO4 was used as a precipitant in the presence of Ca2+, we 
obtained a different crystal form of Mtb PPiase, with only one PPiase 
monomer per asymmetric unit. The Mtb PPiase in this crystal form contained 
two Pi ions bound to the active site, mimicking the products of 
pyrophosphorolysis (Figure A.3B). The P–P distance between the two Pi ions 
in this complex is 4.8 Å, whereas the P–P distance in a PPi molecule is 2.86 
Å, clearly indicating the absence of covalent connectivity between the two P 
atoms. This structure thus appears to correspond to a catalytic state 
immediately after the PPi cleavage, but before dissociation of either Pi. The Pi 
that is adjacent to Asp57/Asp89 is at approximately the same location as the 
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respective phosphate group of the PPi in the previous structure. The other Pi 
is shifted by about 2 Å from the position of the respective phosphate group 
of the PPi towards Lys133, and it forms a hydrogen bond with this residue. 
This Pi interacts both electrostatically and via hydrogen bonds with Arg30, 
Lys127 and Lys133, while maintaining an electrostatic interaction with 
Lys16. This disposition of the two bound Pi molecules is similar to that 
observed in the active site of S. cerevisiae PPiase,46 supporting the notion 
that this structure is a mimic of the first product complex after PPi 
hydrolysis. 
As expected, metal ion M3, which was chelated by the two phosphate 
groups of the PPi substrate in the previous structure, was not observed in 
this Mtb PPiase–2Pi complex (Figure A.3B). M2 ion remains bound in this 
structure, but is shifted by 2.5 Å from the location in the previous structure 
and is no longer directly coordinated directly to Glu8 and Asp57, but still 
maintains salt bridges with these residues. In this complex, M1 ion is also no 
longer present, but a water molecule is found in the vicinity, with strong 
hydrogen bonds to Asp57, Asp89 and to the closest O atom of the adjacent 
Pi (the O–O distances of 2.6–2.8 Å). Both the backbone and the side chain of 
Asp89 are somewhat shifted towards Asp57 and the Pi from the 
conformation of Asp89 in the Mtb PPiase–PPi complex. 
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PPiases from Mtb and E. coli are very highly homologous in sequence 
(46% sequence identity and 62% sequence homology) and in structure  
 
 
Figure A.4. Mtb PPiase and E. coli PPiase comparison. Comparison of 
the active sites of Mtb PPiase (PDB ID: 4Z74; this study) and E. coli PPiase 
(PDB ID: 2AUU) when bound to PPi. The ligands are highlighted as in Figure 
A.1. (A) Conformational differences between the backbones Mtb PPiase (light 
gray) and E. coli PPiase (dark gray). Loops 1 (residues 52–59 of Mtb PPiase) 
and 2 (residues 83–90) are labeled. (B) The active site of Mtb PPiase. (C) 
The active site of E. coli PPiase. A bound fluoride is shown as a blue sphere. 
The residues whose identity or disposition with respect to the PPi differ from 
those of E. coli are shown explicitly in panels (B) and (C). 
 
 (RMSD of Cα–Cα distances is 1.0 Å), and all the active site residues that 
contact PPi or divalent metal ions are the same in the two enzymes. While 
the active site of Mtb PPiase and the bound PPi display a high degree of 
similarity to that observed in the crystal structure of E. coli PPiase in 
complex with PPi, fluoride and Mg2+ (PDB ID: 2AUU), there are significant 
conformational differences in two loops (loop 1: residues 52–59 and loop 2: 
residues 83–90), which contain some of the residues that were previously 
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proposed to play key catalytic roles for the E. coli enzyme (Figure A.4A). 
These differences are not due to crystal packing interactions, as these 
regions of the Mtb PPiase are not involved in crystal packing, nor are they 
due to a different divalent metal ion, as another crystal structure of Mtb 
PPiase with bound PPi and the catalytic Mn2+ (described in the next section) 
is nearly perfectly superimposable onto this structure. Moreover, the 
conformations of these loops in the crystal structure of E. coli PPiase in 
complex with PPi, fluoride and Ca2+ (PDB ID: 1I6T) are nearly identical to 
those in the structure with Mg2+. Major differences are between the 
backbone conformations of these loops; the side chain rotamers of the 
conserved residues of the two PPiases are nearly identical to each other. 
These dissimilarities are also reflected in the geometry of coordination of the 
metal ions and hydrogen bonds with waters by the key metal Asp residues 
residing in these loops (Figure A.4B and C). Most prominently, Asp54 and 
Asp52 are shifted away from the PPi by 3.1 Å and 4.7 Å from its E. coli 
counterparts, Asp67 and Asp65, respectively. As a consequence, Asp54 does 
not form a hydrogen bond with the positionally conserved water W1, which 
was proposed to be activated by Asp67 of E. coli by proton abstraction. 
Other differences include the lack of M1 and M3 coordination by Asp52 and 
Asp84, respectively. This geometry makes the mechanism of water 
activation by Asp54 unlikely. Remaining candidate residues for proton 
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abstraction from a catalytic water, based on proximity of such residues to 
the PPi, are Asp57 and Asp84. 
These conformational differences may result from evolutionary 
divergent sequences of Mtb and E. coli PPiases. For example, His21, one of 
the two His unique to Mtb,24 is wedged between Asp54 and Phe44, forming a 
salt bridge with Asp54, a hydrogen bond with the carbonyl oxygen of Val19 
stacking perpendicularly with Phe44 and sterically interacting with Pro55. 
Thus, His21 appears to keep loop 1 away from the PPi. In contrast, Lys34 of 
E. coli points out of the protein interior into the solvent. In loop 2, the other 
unique His, His86, corresponds to the much smaller Ala99 of E. coli. The Cα 
of His86 is shifted by 2.7 Å from the respective Cα of Ala99 away from the 
PPi, likely to preserve metal ion coordination by Asp residues, and, as a 
result, loop 2 is also shifted. These significant conformational differences 
imply potential mechanistic differences between the Mtb and the E. coli 
PPiases. 
Structures of Mtb PPiase in complex with one Pi and apo-Mtb 
PPiase. When crystals of Mtb PPiase were grown at high HPO42− 
concentration in the presence of Mn2+, the crystals again contained two 
hexamers of the enzyme per asymmetric unit. The structure, determined at 
a resolution of 3.3 Å revealed that active sites of 9 of the 12 monomers 
contained one Pi ion and the other 3 sites contained a PPi molecule. Because 
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of the lower resolution of this structure, we were able to distinguish only the 
PPi/Pi ligands and Mn2+ ions. The locations of the Mn2+ ions were also 
confirmed by the anomalous difference Fourier map. Bound water was not 
resolvable. The PPi was bound similarly to its position in the structure 
described in the previous section, indicating that the differences between the  
 
Figure A.5. Mtb PPiase bound with Pi and Mn2+. The active site of Mtb 
PPiase in the structure of its complex with Pi and Mn2+. The active site 
contains a Pi molecule bound at a location in a positively charged cleft that 
overlaps with the phosphate group of the PPi that is not directly attacked. 
Metal ion M1 occupies a similar position in both the Pi and the PPi bound 
structures; however, metal ion M2 has shifted closer to the bound Pi. No 
other metal ion is observed in this structure. 
 
structures of Mtb and E. coli PPiase are not due to different divalent metal 
ions. The location of the bound Pi was almost exactly in the middle of the 
two Pi ions seen in the complex of Mtb PPiase with two Pi ions. This Pi 
position closely corresponds to the location of the Pi group of the bound PPi 
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that is not directly attacked. In this structure, the Pi still interacts with 
Arg30, Lys127, and Lys16, but not with Lys133 (Figure A.5). This structure 
is similar to that reported previously in the absence of divalent metal ions 
(PDB ID: 1WCF).23 Notably, the location of this remaining Pi is also 
consistent with that seen in structures of S. cerevisiae in an elegant 
crystallographic study by Oksanen.46 Therefore, this structure is likely a  
 
Figure A.6.  Metal binding positions of Mtb PPiase. (A) The active site 
of Mtb PPiase in the structure of its complex with Mg2+. The active site 
contains metal ions in the M1 and M3 positions. (B) The active site of Mtb 
PPiase in the structure of its complex with Ca2+. The sole bound metal ion is 




mimic of a subsequent mechanistic intermediate, formed after one of the 
two Pi products has dissociated.  Taken together, the above structures of the 
Mtb PPiase–PPi/2Pi/Pi complexes strongly suggest that the directly attacked 
phosphate group of the PPi is first to dissociate as a Pi, since the remaining Pi 
maintains most of its electrostatic interactions in this mechanism, as 
described above. Site M1 is occupied (by Mn2+), and the other bound metal 
ion is shifted from the previously observed site M2 by 3.2 Å towards the Pi. 
Crystal structures of Mtb PPiase were also determined in the presence 
of only divalent metal ions, without the substrate or the product (PPi or Pi), 
to capture the state(s) of the enzyme prior to binding of the PPi substrate or 
after the dissociation of the reaction products. Specifically, structures of apo-
Mtb PPiase bound to Mg2+ ion (Figure A.6A) and to Ca2+ ion (Figure A.6B) 
were determined at resolutions of 1.85 Å and 1.95 Å, respectively. In the 
complex with Mg2+, the active site contains two bound Mg2+ ions. One cation 
is bound at the M1 site, with the same adjacent water molecule as in the 
structures of complexes with PPi and Pi. The other Mg2+ is bound to the 
protein exclusively through water mediated interactions, at a site shifted 
from the original M3 site by 3.8 Å towards Asp89. The structure of the Mtb 
PPiase in complex with Ca2+ contains only one metal ion in the active site 
near the M1 site, where the Ca2+ is coordinated to Asp57 and Asp52 instead 
of Asp89 due to a minor positional shift. Minor differences were observed in 
the conformations of the side chains coordinating the divalent metal ions, 
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which may be due to different sizes or coordination propensities of Mg2+ and 
Ca2+. The remaining metal ion, M2, is observed only together with bound PPi, 
2Pi or Pi and, therefore, this metal ion and PPi likely bind the enzyme in a 
cooperative fashion. 
 
Figure A.7. Optimized reactant structure comparison. Comparison of 
the immediate active site between the crystal structure (A) and the 




Figure A.8. Comparison of optimized product structure. Comparison of 
the immediate active site between the crystal structure (A) and the 
optimized product (B) structure. The phosphoanhydride bond of the PPi has 
been broken by Wc. 
 
QM/MM calculations of the central catalytic step. As the 
mechanism of water activation by Mtb PPiase appears to be distinct from the 
E. coli homolog, to characterize this process for Mtb PPiase, we carried out 
QM/MM simulations. At the initial stage, the QM/MM simulations involved 
optimization of the reactant and product structures. The reactant structure 
was optimized starting from the structure of Mtb PPiase–PPi complex (Figure 
A.7A). The final optimized reactant structure (Figure A.7B) had an overall 
backbone RMSD deviation of 0.9 Å and an RMSD for all atoms in the active 
site of 0.6 Å with respect to the crystal structure of the Mtb PPiase–PPi 
complex. As an internal consistency check, the product structure was 
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modeled in silico from the optimized reactant structure and subjected to 
QM/MM optimization. 
The initial calculations were performed with the PPi completely de-
protonated (−3 charge), which did not yield an optimized product structure 
starting from the optimized reactant. Subsequently, a proton was added to 
one of the oxygen atoms on the phosphate group that was not directly 
attacked (Figure A.7B), which enabled the optimization of both the reactant 
and product structures. The optimized product structure (Figure A.7B) had 
an overall backbone RMSD of 0.9 Å and an all-atom RMSD for the active site 
of 0.8 Å with respect to the crystal structure of the Mtb PPiase–2Pi complex 
(Figure A.8A). Thus, neither optimized structures were significantly 
perturbed relatively to the reference crystal structures. Moreover, the low 
RMS deviation of the optimized product structure with respect to the Mtb 
PPiase–2Pi crystal structure underscores the applicability of our method. The 
overall calculated reaction energy for this process was −11.24 kcal/mol. 
Upon replacing the three Ca2+ atoms in the active site with Mg2+ and 
subjecting the structure to MD and QM/MM optimization, a shift in the active 
site is observed. In the optimized reactant structure (Figure A.7B), the 
change in cations results in a tighter active site, as an apparent result of the 
shorter coordination bonds between the carboxylate oxygens of the 
aspartates and the metal ions. For example, the distance between Asp57 
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and M1 changes from 2.52 Å to 2.08 Å. This tightening promotes a 
rearrangement of the active site, which results in the loss of coordination 
between Asp89 and M3, while improving coordination of this residue with M1. 
The catalytic water molecule is observed to travel starting from a site 
occupied by water W1 in the Mtb PPiase–PPi complex (Figure A.3A) in the 
reactant species and get activated (in the TS) at a site approximately 
halfway between W1 and W2 in that complex. In addition, the attacking 
water is observed to form hydrogen bonds to both Asp89 and Asp57. The 
hydrogen bond between the attacking water, Wc, and Asp89 is slightly 
stronger than to Asp57 as judged by the respective O–O distances (Figure 
A.7B).  The optimized reactant and product structures were used as starting 
points for the Quadratic String Method (QSM) calculation.44 Once the path  
 
Figure A.9. Optimized transition state of Mtb PPiase, Optimized 
transition state corresponding to a concerted mechanism where the 





was optimized, the highest energy point was selected and optimized to the 
transition state (TS) (Figure A.9) by a QST3 optimization, resulting in a final 
structure with one single imaginary frequency of 240.8i cm−1. The final 
calculated barrier for the hydrolysis of PPi by Mtb PPiase is 6.6 kcal/mol. 
There have been a number of theoretical studies on other phosphatases and 
phosphate hydrolysis.47-52 However, to our knowledge, only one study has 
been reported on an inorganic pyrophosphatase, with E. coli PPiase.53 The 
authors of this study reported a calculated barrier (for a cluster model with 
continuum solvation) of ≈ 9 kcal/mol. This barrier is similar to our calculated 
barrier of 6.6 kcal/mol, especially taking into account that the present 
results explicitly include the entire enzyme and solvent into the calculation. 
These calculations indicate that the carboxylate oxygen of Asp89 
forming the hydrogen bond with Wc abstracts a proton from this water, as 
this residue becomes both nucleophilic due to the loss of one of the two 
coordinating metal ions and due to its proper positioning with respect to Wc. 
In contrast, both oxygens of Asp57 remain coordinated to two divalent metal 
ions, apparently remaining insufficiently nucleophilic. Based on the minimum 
energy path, the nucleophilic water transfers a proton to Asp89 to yield a 
hydroxyl anion and almost concomitantly carries out the nucleophilic attack 
on the adjacent P atom of the PPi. 
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To test directly the possibility for proton abstraction by Asp57, an 
initial structure was generated where the phosphodiester bond was broken 
and the proton from the nucleophilic water was transferred to the closes 
carboxyl oxygen of Asp57. This initial structure was subjected to the same 
optimization procedure as that used above. Interestingly, the final optimized 
structure involved the return of the proton from Asp57 to the water O and 
the transfer of the other proton to Asp89. This suggests, that the carboxyl 
oxygen on Asp89 that is not coordinated to Mg2+ is a better proton acceptor. 
Effects of mutations of Asp54, Asp57 and Asp89 on PPi 




Figure A.10. Mtb PPiase and mutant kinetic curves. The analysis of the 
steady-state hydrolysis by wild-type Mtb PPiase (circles) and its three 
mutants: Asp54Asn (squares), Asp57Asn (triangles) and Asp89Asn 
(diamonds). (A) Activity measurements for reactions with 2 nM of each 
enzyme. The curves show the best fit to the Michaelis–Menten equation with 
Km = (64 ± 3) μM and kcat = (48 ± 1) s−1 for wild-type Mtb PPiase and Km = 
(131 ± 19) μM and kcat = (14 ± 1) s−1 for Asp54Asn mutant. The amount of 
product formed by the other two mutant enzymes, Asp57Asn and Asp89Asn 
was insignificant at these enzyme concentrations. (B) Activity measurements 
for reactions with 800 nM of Asp57Asn and Asp89Asn mutants. The best-fit 
curves correspond to Km = (38 ± 17) μM and kcat = (0.17 ± 0.02) s−1 for 
Asp57Asn and Km = (14 ± 5) μM and kcat = (0.087 ± 0.005) s−1 for 
Asp89Asn mutant. The standard deviations were invariably of the size of the 
data symbols or smaller and, therefore, the error bars were not shown. 
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structural and computational studies, we performed steady-state 
measurements of the pyrophosphatase activity by wild-type Mtb PPiase and 
its point mutants of three relevant Asp residues to an Asn: Asp54Asn, 
Asp57Asn and Asp89Asn. An Asn was chosen, since it is approximately 
isosteric with an Asp and is not a proton abstractor. The activity of the 
Asp54Asn is only modestly perturbed, as establish by steady-state kinetic 
measurements with the concentration of the enzymes of 2 nM (Figure 
A.10A): the value of kcat for this mutant is 3-fold smaller and the value of Km 
is 2-fold larger than those for the wild-type enzyme. The activity of the other 
two mutant enzymes, Asp57Asn and Asp89Asn, is insignificant at this 
concentration (Figure A.10A). These results, in agreement with our proposal, 
indicate that Asp54 does not play a major catalytic role, and another residue 
(e.g., Asp89) acts as a base instead. The kinetics of the two weakly active 
mutants were measured quantitatively in assay where they were present at 
800 nM each (Figure A.10B). While their Km values are within 2- to 3-fold 
range from that of the wild-type enzyme, the kcat values for Asp57Asn and 
Asp89Asn mutants are 300-fold and 600-fold smaller, respectively. Even 
though these observations are also consistent with our proposed 
mechanism, due to a possible perturbation of Mg2+ coordination in these 






It was previously reported that family I PPiases could catalyze the 
reverse reaction to combine two molecules of Pi into a PPi with a remarkable 
catalytic efficiency.4 The use of Pi, a sole reactant of this reverse reaction at 
a high concentration (in the molar range) in the crystallization solution 
allowed us to capture Mtb PPiase with a PPi bound in the active site in the 
crystalline form. We also obtained crystals of Mtb PPiase bound to reactants 
and products together with divalent metal ions and coordinated water 
molecules. While previous structural studies of E. coli and S. cerevisiae 
PPiases postulated the location of a nucleophilic water based on the 
observation of an inhibitory fluoride ion, considered to be a mimic of the 
hydroxide nucleophile,11, 13 the present study addressed structural and 
mechanistic details of water activation through both crystal structure 
analysis and computational QM/MM simulations. Significant structural 
differences in the active sites of Mtb and E. coli PPiases strongly suggest a 
distinct water activation mechanism for the Mtb homolog. We observed at 
least two water molecules in the structure of Mtb PPiase–PPi complex that 
could in principle serve the catalytic role, based on their proximity to the 
bound PPi (Figure A.3A). Because Asp54 (a counterpart of Asp67 proposed 
as the general base for E. coli PPiase) is too far from the PPi and the bound 
water molecule to serve as a proton abstractor, Asp57 and Asp89 are 
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potential candidates for this role, as they are located in close enough 
proximity to PPi. Indeed, our biochemical studies demonstrated that the 
Asp54Asn mutant retains significant catalytic activity (the mutation 
decreases kcat only 3-fold), implicating either Asp54 or Asp89 in proton 
abstraction. The QM/MM simulations resolved this ambiguity and established 
that Asp89 could function to deprotonate the catalytic water, with very 
minor conformational changes in the active site. Even though for E. coli 
PPiase the effect of the analogous mutation (Asp67Asn) is greater (a 26-fold 
decrease in kcat),14 even in that system it is too small to account for this Asp 
as the sole catalytic base. Furthermore, analogs of Asp57Asn and Asp89Asn 
mutants in E. coli PPiase (Asp70Asn and Asp102Asn) resulted in lesser 
defects in the hydrolytic activity (150-fold and a 90-fold, respectively) than 
in Mtb PPiase (300- and 600-fold). The potential of Asp89 to act as an 
alternative general base is a novel finding, which not only suggests a likely 
activation mechanism for the Mtb PPiase, but provides an alternative, back-
up mechanism for E. coli PPiase, explaining the modest effects on catalysis 
of mutating Asp67 in that homolog. This back-up catalytic strategy is likely 
common among enzymes of this family ensuring their robustness, as there is 
usually no redundant cytoplasmic phosphatase that is able to hydrolyze 





Figure A.11. Proposed Mtb PPiase mechanism. A proposed mechanism 
of the catalytic turnover of PPiase. Complex i: PPiase bound to metal ion M1. 
Complex ii: PPiase bound to metal ions M1 and M3. Complex iii: PPiase bound 
to all three metal ions and the substrate, PPi. Complex iv: Pre-catalytic 
complex formed as a result of binding of the catalytic water. Complex v: 
Post-catalytic complex PPiase–2Pi formed after hydrolysis and the release of 
metal ions M1 and M3. Complex vi: Post-catalytic complex formed after 
release of one of the Pi products. Metal ion M2 is shifted closer to the 
remaining Pi. Release of this Pi and the metal ion M2 returns the enzyme to 
its initial state. 
 
proposed for a catalytic Asp of an unrelated enzyme, triacylglycerol lipase 
from Pseudomonas glumae.54 
A collection of crystal structures of Mtb PPiase – alone, bound to a PPi, 
to two Pi ions and to one Pi ion provided us with a complete set of major 
mechanistic intermediates in the enzymatic turnover pathway for this 
enzyme (Figure A.11). These structures allowed us to refine the previous 
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mechanistic proposal (species i and v in Figure A.1), and they strongly 
suggest that the catalytic water is not bound in the active site prior to the 
PPi binding, or if it is bound, it is positioned appropriately only upon PPi 
binding. The structures also suggest that M3 ion binds prior to PPi, but that 
M3 binding is likely stabilized in the presence of PPi. M3 dissociates after the 
PPi hydrolysis step, likely because the proper bidentate coordination to the 
two Pi products cannot be maintained. In contrast, M2 binding depends 
strictly on binding of PPi or the presence of at least one of the Pi products 
and is also likely cooperative with PPi/Pi binding, as M2 ion is observed only 
in the presence of phosphate ligands and not in apo-enzyme structures. 
After the hydrolysis, but before dissociation of the first Pi, M1 ion is 
apparently destabilized and dissociates, likely because of disruptions in the 
hydrogen bonding and coordination with water as a result of hydrolysis. The 
Pi that is adjacent to Asp57 and Asp89 likely dissociates first of the two Pi 
products. The dissociation of the first Pi is likely driven by the repulsion 
between the two Pi products and, likely, by destabilizing structural 
perturbations at the catalytic center (near Asp57 and Asp89), whereas the 
remaining Pi ion maintains its favorable electrostatic interactions with the 
protein. This order of dissociation of the two Pi products is the opposite of 
that previously depicted in the E. coli PPiase mechanism (Figure A.1, species 
iv) proposed based on studies of crystals generated in the presence of 
inhibitory fluoride and then gradual soaking this fluoride out of the 
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crystals.11 On the other hand, our proposed order of Pi dissociation is 
consistent with other structural studies of both E. coli and S. cerevisiae 
PPiases.25, 46 After the first Pi dissociates, M1 rebinds, as its coordination can 
likely be again satisfied due to increased flexibility of the Asp side chains and 
water molecules in the active site. On the other hand, metal ion M2 rather 
than dissociating, progressively shifts its position towards the remaining Pi, 
as seen in the structures of Mtb PPiase–2Pi (Figure A.2B) and Mtb PPiase–Pi 
complexes (Figure A.5). This shift is sterically allowed by the dissociation of 
the first Pi. 
The structural and computational information gained in this and earlier 
studies allow us to propose a more elaborate mechanistic scheme (Figure 
A.11). In this scheme, divalent metal ion M3 binds to PPiase that is already 
bound to divalent metal ion M1 (Figure A.11, species i and ii), likely in an 
equilibrium process. Binding of M1 and M3 enables binding of PPi and divalent 
metal ion M2 (Figure A.11, species iii). These binding events are followed by 
binding and/or repositioning of the already bound catalytic water molecule 
(Figure A.11, species iv), which can then become deprotonated by Asp89 
and attack the adjacent phosphate group of PPi. After catalysis, ion M3, 
which was chelated by both phosphate groups of the PPi, leaves the active 
site (Figure A.11, species v). Upon destabilization of the electrostatic 
interactions and the hydrogen bonding network due to the hydrolysis, the Pi 
closest to M1 and M2 dissociates from the active site leaving the other Pi 
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along with original metal ion M1 as well as metal ion M2, which is shifted 
from its original location towards the remaining Pi (Figure A.11, species vi). 
Finally, the Pi and M2 dissociate from the active site thereby restoring the 
initial state of PPiase for a new catalytic cycle. 
Two histidine residues (His21 and His86) in the vicinity of the catalytic 
center have been of interest, as they are major features distinguishing the 
Mtb PPiase from other characterized PPiases.23, 24 Kinetic studies of mutant 
Mtb PPiase have shown that His21 and His86 likely function in divalent metal 
ion selectivity, as wild-type Mtb PPiase is inhibited by Zn2+ but not Mg2+, 
whereas the single and the double alanine mutants of these residues are 
active with both divalent metals.24 Our structural data support the idea that 
these His residues are not directly involved in normal catalysis. In addition, 
our structures suggest that these His residues are involved in the distinct 
conformation of the active site loops bearing Asp residues that are engaged 
in metal ion coordination or water activation, ultimately dictating distinct 
mechanistic features. In summary, this study combining structural and 
computational analyses, clarifies the description of the water-mediated 
hydrolysis in family I PPiases and suggests a defined sequence of cofactor 
and substrate binding and dissociation events during the catalytic turnover. 
Bacterial PPiases are essential enzymes and, therefore, are potential 
targets for inhibition by small molecules. Discovery of such inhibitors should 
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be enabled by development of assays amenable to high-throughput 
screening (HTS).18 Low-μM diphosphonate inhibitors selective for 
mammalian inorganic pyrophosphatases have been reported.55 A recent HTS 
campaign yielded the first non-ionic inhibitory compounds with IC50∼30 
μM.19 Through a deeper understanding of the catalytic mechanism, the 
unique features of Mtb PPiase, such as the disposition of the active site Asp 
residues and the two His residues discussed above, may be used as 
specificity determinants in future development of selective inhibitory 
compounds against this enzyme. The structures described here could guide 
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ESI FT-ICR MS SPECTRA OF LPS SAMPLES GENERATED FROM WOD02 
Obs Mass Calc Mass Chemical Composition 
1178.66 1178.661 2*GlcN, 2*P, 3*(OH)-14:0 
1404.85 1404.854 2*GlcN, 2*P, 4*(OH)-14:0 
1484.82 1484.820 2*GlcN, 3*P, 4*(OH)-14:0 
1527.56 1527.863 2*GlcN, 2*P, 4*(OH)-14:0, 1*P-EtN 
1624.91 1624.912 2*GlcN, 2*P, 4*(OH)-14:0, 1*Kdo 
1747.92 1747.920 2*GlcN, 2*P, 4*(OH)-14:0, 1*Kdo, 1*P-EtN 
1766.09 1766.092 2*GlcN, 2*P, 4*(OH)-14:0, 1*16:0 
1800.94 1800.944 2*GlcN, 2*P, 3*(OH)-14:0, 1*12:0, 2*Kdo 
1816.98 1816.976 2*GlcN, 2*P, 4*(OH)-14:0, 1*Kdo, 1*Hep 
1835.11 1835.111 2*GlcN, 2*P, 4*(OH)-14:0, 1*14:0, 1*Kdo 
1844.97 1844.971 2*GlcN, 2*P, 4*(OH)-14:0, 2*Kdo 
1881.91 1880.911 2*GlcN, 3*P, 3*(OH)-14:0, 1*12:0, 2*Kdo 
1994.01 1993.008 2*GlcN, 2*P, 3*(OH)-14:0, 1*12:0, 2*Kdo, 1*Hep 
2000.15 1999.142 2*GlcN, 2*P, 4*(OH)-14:0, 1*12:0, 1*Kdo, 1*Hep 
2018.28 2017.278 2*GlcN, 2*P, 4*(OH)-14:0, 1*14:0, 1*12:0, 1*Kdo 
2028.14 2027.137 2*GlcN, 2*P, 4*(OH)-14:0, 1*12:0, 2*Kdo 
2073.98 2072.974 2*GlcN, 3*P, 3*(OH)-14:0, 1*12:0, 2*Kdo, 1*Hep 
2108.11 2107.104 2*GlcN, 3*P, 4*(OH)-14:0, 1*12:0, 2*Kdo 
2141.29 2140.286 2*GlcN, 2*P, 4*(OH)-14:0, 1*14:0, 1*12:0, 1*Kdo, 1*Hep 
2220.21 2219.201 2*GlcN, 2*P, 4*(OH)-14:0, 1*12:0, 1*Kdo, 1*Hep 
2238.34 2237.336 2*GlcN, 2*P, 4*(OH)-14:0, 1*14:0, 1*12:0, 2*Kdo 
2248.20 2247.196 2*GlcN, 2*P, 4*(OH)-14:0, 1*12:0, 3*Kdo 
2300.17 2299.167 2*GlcN, 3*P, 4*(OH)-14:0, 1*12:0, 1*Kdo, 1*Hep 
2318.31 2317.302 2*GlcN, 3*P, 4*(OH)-14:0, 1*14:0, 1*12:0, 2*Kdo 
2328.17 2327.162 2*GlcN, 3*P, 4*(OH)-14:0, 1*12:0, 3*Kdo 
2429.89 2429.89 ECA 
2430.40 2429.399 2*GlcN, 2*P, 4*(OH)-14:0, 1*14:0, 1*12:0, 2*Kdo, 1*Hep 
2458.40 2457.394 2*GlcN, 2*P, 4*(OH)-14:0, 1*14:0, 1*12:0, 3*Kdo 
2510.37 2509.366 2*GlcN, 3*P, 4*(OH)-14:0, 1*14:0, 1*12:0, 2*Kdo, 1*Hep 
2538.36 2537.360 2*GlcN, 3*P, 4*(OH)-14:0, 1*14:0, 1*12:0, 3*Kdo 
2650.46 2649.458 2*GlcN, 2*P, 4*(OH)-14:0, 1*14:0, 1*12:0, 3*Kdo, 1*Hep 
 
Table B.1. Mass spectrometric data table. List of mass peaks of LPS 
analogs identified.  Due to isotopic distributions above 1844.97 major peaks 
are 1 u higher.  
Figure B.1. Mass spectra from WOD02 and derivatives. (A-U) Mass 





A. Mass spectrum of WOD02 with mass units of m/z.  
 




C. Mass spectrum of WOD05 with mass units of m/z.  
 




E. Mass spectrum of WOD07 with mass units of m/z.  
 




G. Mass spectra of WOD08-11 which lack Kdo transferases with mass 





H. Mass spectra of WOD13 with mass units of m/z.  
 




J. Mass spectra of WOD15 with mass units of m/z.  
 




L. Mass spectra of WOD18 with mass units of m/z.  
 




N. Mass spectra of WOD20 with mass units of m/z.  
 




P. Mass spectra of WOD22 with mass units of m/z.  
 




R. Mass spectra of WOD24 with mass units of m/z.  
 




T. Mass spectra of WOD26 with mass units of m/z.  
 





hTLR4 ACTIVATION BY VARIABLE LPS OF WOD02 DERIVATIVES 
 
Figure C.1. Activation of hTLR4 by LPS from WOD02 derivatives.  
Measure of hTLR4 activation by SEAP secretion in triplicate.  Total activities 
are compared to commercial full-length E. coli K-12 LPS (100% activation).  
Samples include Rasor02 with (A) HiWaaA, (B) EcWaaA, (C) CtWaaA, (D) 








































































































































































































































DNA SEQUENCE OF KD8N PRODUCING SYNTHETIC OPERON 
 
Figure D.1. Sequence of synthetic genes for Kd8N generation. 
Synthetic codon optimized sequence of the engineered Kd8N biosynthetic 
genes from S. oneidensis MR-1 
        1 TAATACGACT CACTATAGGG GAATTGTGAG CGGATAACAA TTCCCCTCTA GAAATAATTT 
       61 TGTTTAACTT TAAGAAGGAG ATATACATAT GGTGGATCAA TCACAACTGC GTCAATGGGG 
      121 CTGTAAAGTC ATCGACATCG AAAAATCGGC ACTGGACAAC CTGTATCAAT ATGTTGATTC 
      181 TGCCGAATTT GCACAGGCTT GCGAACTGAT TCTGAACTGT TCAGGCAAAG TGATCGTTAT 
      241 GGGCATGGGT AAATCGGGCC ATATTGGTAA TAAAATCAGC GCTACCCTGG CCTCTACCGG 
      301 TACGCCGGCC TTTTTCGTTC ATCCGGGTGA AGCAAGTCAC GGCGATCTGG GTGTCCTGTC 
      361 CGATAACGAC ATTATCCTGG CCATTTCAAA TTCGGGCGAA AGCTCTGAAA TTCTGGCACT 
      421 GATGCCGGTG ATCCAGCGTA AAGCTATTCC GGTTATCGCG ATGACCGGTA AACCGGAAAG 
      481 CACGATGGCC CGCCTGGCAA AAATTCATCT GTGCATCGAA GTTCCGGAAG AAGCCTGTCC 
      541 GCTGGGTCTG GCACCGACCA GTTCCACCAC GGCCACGCTG GTGATGGGCG ATGCGATGGC 
      601 CATTGCACTG CTGCAAGCAA AAGGTTTTAC CCGTGATGAC TTCGCTATGA GCCACCCGGG 
      661 CGGTGCGCTG GGCCGTAAAC TGCTGCTGAA AGTCTCTAAC GTGATGCATT GCGGTGATGA 
      721 CCTGCCGCTG GTTAAACACG ATATTTGTAT CACCGACGCT CTGTATGAAA TTAGCAAGAA 
      781 AGGCCTGGGC ATGACGGCGA TTATCGATGA ACAGAACAAA CTGGTGGGCA TTTTCACCGA 
      841 TGGTGACCTG CGTCGCGTTA TCGATGCTCA AGTCAATCTG CGTACCACGC CGATTGCGGA 
      901 CGTGATGACC CGCAACTGCG TTACCATCAC GGAAAATGTC CTGGCGGCCC AGGCGCTGCA 
      961 AGTCATGGAT AGCCGTAACA TTAATGGCCT GATTGTGATC GACAAAGAAA ATCATCCGGT 
     1021 TGGTGCCCTG AATATGCTGG ACATGGTCAA AGCGGGTGTT ATCTGAGAAT TCTAATACGA 
     1081 CTCACTATAG GGGAATTGTG AGCGGATAAC AATTCCCCAC TAGAAATAAT TTTGTTTAAC 
     1141 TTTAAGAAGG AGTATACACA TGAGCAACAA AATTATTAAA CTGGGTTCTA TTGAAATCGC 
     1201 AAATGACAAA CCGTTCGTCC TGTTCGGCGG CATGAATGTC CTGGAAAGTC GTGATCTGGC 
     1261 GATGTCCATT GCCGAAACCT ATGCAGAAGT GACGCAGAAA CTGGGCATCC CGTACGTTTT 
     1321 TAAAGCCTCA TTCGACAAAG CAAACCGTAG CTCTGTGAAT TCGTATCGCG GCCCGGGTAT 
     1381 GGAAGAAGGT CTGAAAATCT TTGAAGAAAT TAAGAAAACC TTCAACCTGC CGCTGATTAC 
     1441 CGATGTCCAT GAAACCTATC AGTGTGCCCC GGTGGCCGAA GTGGTTGATA TTATCCAGCT 
     1501 GCCGGCATTT CTGGCTCGCC AAACCGACCT GGTCGTGGCG ATGGCCAAAA CGGGCGCGAT 
     1561 CATCAACGTT AAAAAACCGC AATTCCTGGC CCCGCATGAA ATGCGTCACA TTATCACCAA 
     1621 ATTCAACGAA GCGGGTAATG ATGAAATTAT CCTGTGCGAA CGCGGCTCCT GTTTTGGTTA 
     1681 TAACAATCTG GTTGTCGATA TGCTGGGCAT GGACGAAATG AAACAGAGCG GTTACCCGGT 
     1741 CATTTTCGAT GCGACCCATG CACTGCAACG TCCGGGCGGT CGTGCAGACA GCGCTGGCGG 
     1801 TCGTCGCGCA CAGGCTACCG AACTGGCCCG TTCTGGTATG GCTCTGGGCC TGGCGGGTCT 
     1861 GTTCATCGAA GCTCATCCGG ACCCGGACAA CGCAAAATGT GATGGTCCGT GTGCACTGCC 
     1921 GCTGCACCAA CTGGAAAATT ATCTGAAACA GATGAAAGCG ATTGATGACC TGGTGAAAAG 
     1981 TTTTGAACCG ATTGATACCT CGAAATAAGG AGAGCTCTCT AATACGACTC ACTATAGGGG 
     2041 AATTGTGAGC GGATAACAAT TCCCCACTAG AAATAATTTT GTTTAACTTT AAGAAGGAGA 
     2101 TATACACATG CCGCAACAGG GCTTCTACGG TCCGGTTAGC GATGATGTGT GGCAACGTGC 
     2161 TCAAAAAATT AAACTGCTGA TCTGCGATGT GGATGGCGTG TTTAGCGATG GTCGTATTTA 
     2221 TCTGAGCAAC TCTGGCGAAG AACTGAAAGC ATTTCATACC CGTGACGGCT ACGGTGTGCG 
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     2281 CAGTCTGCTG ACCAGCGGCT TCCACCTGGC AGTGATTACG GGTCGTCAGT CACGCATCGT 
     2341 TGAAAATCGC ATGACCGCTC TGGGCGTCAC GCATATCTAC CAAGGTGTGG ATAACAAATT 
     2401 CGTTCCGTAT GAAGAACTGC TGTCGATCTA CAATGTCACC GCGGAAGAAG TGGCCTACAT 
     2461 TGGCGATGAC ATCGTTGATC TGCCGGTCAT GAACGTGGTT GGCCTGGCAG TCTGCGTGGC 
     2521 TGACGGTCAT CCGTATGTTC GTCAGCATGC GCACTTCGTC ACGCAACTGA ATGGCGGTCA 
     2581 CGGTGCCCTG CGCGAACTGA CGGACCTGCT GCTGCTGTCG CAAAATAAAT TCACCTCGGC 
     2641 TCACGGCATG TCTATCTAAG GAAGATCTGT CGACTCTAAT ACGACTCACT ATAGGGGAAT 
     2701 TGTGAGCGGA TAACAATTCC CCCCTAGGAA TAATTTTGTT TAACTTTAAG AAGGAGATAT 
     2761 TAATATGTCG TTCAAAAACT TCAAAGTGGT GGAAAAAATG ATCTTCGGTC GTGGCTCGTT 
     2821 CGTTCAACTG GATGATGTCC TGGCGGCTCA GCGTAAAGCG GATGACGATT TTGTGGTTTT 
     2881 CCTGGTCGAC GATGTGCATC AGGGTAAACC GCTGGAAGCA CGCATTCCGG TGAAAGCTCA 
     2941 GGATCTGCTG ATCTGGGTTA ACGTCGACGA AGAACCGAGC ACCATTCAGA TCGATGCGCT 
     3001 GACGGAACAG GTTCAAGCCT TTAATGGTAA ACTGCCGGTC AGCGTCGTGG GCCTGGGCGG 
     3061 TGGCTCTACC ATGGATGTTG CGAAAGCCGT CAGTCTGATG CTGACGAACC CGGGTGGCTC 
     3121 CGCGATGTAC CAGGGTTGGG ATCTGATCAA AAAACCGGCC GTTCATCACA TTGGCATCCC 
     3181 GACCATCAGC GGTACGGGCG CAGAAGCTTC GCGTACCGCA GTGCTGTGCG GTCCGGTTCG 
     3241 CAAACTGGGC CTGAACAGCG ACTATACGGT CTTTGATCAG ATTATCATGG ACTCTGAACT 
     3301 GATTGATGGT GTTGAAACCG ACCAATGGTT CTACACGGGC ATGGATTGCT ATATCCATTG 
     3361 TGTGGAATCA CTGGAAGGCA CCTTTCTGAA TGAATTCTCG AAAGCGTACG CCGAAAAAGC 
     3421 CATGGATCTG TGTCGTCAGG TTTATCTGGA AGACCATCCG GAAAAAGACG ATAAACTGAT 
     3481 GATGGCATCA TTTATGGGTG GCATGAGCAT TGCTTACTCT CAAGTCGGTG CATGCCACGC 
     3541 TGTGAGTTAT GGTCTGTCCT ACATCCTGGG CTATCATCAC GGTATTGGCA ACTGTATCGC 
     3601 ATTTGATGTG CTGGAAGAAT TCTATCCGGA AGGCGTTGCT GAATTCCGCC TGATGATGAA 
     3661 AAAACACAAC ATTACCCTGC CGAAAAATAT CTGCAAAGAC CTGCCGGATG AAACCATTGC 
     3721 GAAAATGGTG GCCGTTACGA AATCCATGGG TCCGCTGTGG GCCAATGTGT ATGGCCCGAC 
     3781 CTGGGAAGAA AAAGTGACCG ATGAAATGCT GACCGCCCTG TTCCGCCGTA TCTGAGGATC 
     3841 TAATACGACT CACTATAGGG GAATTGTGAG CGGATAACAA TTCCCCACTA GAAATAATTT 
     3901 TGTTTAACTT TAAGAAGGAG ATATACATAT GCCGGGCTTT GAACTGTTTG GTCCGGAAGA 
     3961 AAAACAAGAA GTCGCAGACG TGATGGAACA TGGCTTTACC TTTCGCTACA ACTTTGATCA 
     4021 CATGCGTAAC GACCGCTGGA AAACCCGTGA TATGGAACAG CTGCTGTGCG AAAAAATGAA 
     4081 TGTGAAACAT GCACACCTGC TGAGCTCTGG TACCGCGGCC CTGCAAACGG CGATGATGGC 
     4141 AGCTGGCATT GGTGCCGGCG ATGAAGTGAT CGTTCCGCCG TTTACCTTCG TCGCGAGTGT 
     4201 GGAAGCCATT TTTATGGCAG GCGCTGTTCC GATTTTCGCC GAAATCGACG AAACGCTGTG 
     4261 CCTGTCCCCG GAAGGTATTG AAGCAGTCAT CACCCCGCGC ACGAAAGCTA TTAACCTGGT 
     4321 GCACATGTGT GGCTCAATGG CAAAAATGGA TGAAATCAAA GCTATCTGCA AAAAACATAA 
     4381 TCTGGTTCTG CTGGAAGACG CATGTCAGGC TATTGGCGGT TCGTATAAAG GCCAAGCGCT 
     4441 GGGTACCATC GGCGATGTTG GTTGCTACAG TTTTGACTCC GTCAAAACCA TTACGTGTGG 
     4501 TGAAGGCGGT GCCGTCATTA CCAACAATAC GGAAATCTAT GATAACGCAC ACATGTTTTC 
     4561 CGATCATGGC CACGACCATA TCGGCAAAGA CCGTGGTGCG GAAAGCCATC CGATTATGGG 
     4621 CCTGAACTTC CGCATCTCTG AAATGAACGC CGCCCTGGGT CTGGCCCAGC TGCGTAAACT 
     4681 GGATACCATC ATCGACATCC AACGCAAAAA CAAGAAAGCG ATCAAAGATG CGATGGCCAG 
     4741 TATCCCGGAA GTGTCCTTTC GTGAAATCCC GGACCCGGAA GGCGACTCAG CAGGTTTTCT 
     4801 GTCGTTCATG CTGCCGACCG AAGCTCGCAC GCAGGAAATT AGCAAAAAAC TGGCAGCTAA 
     4861 CGGCGTGGAT GGTTGTTTCT ATTGGTATGT GAACAATTGG CACTATCTGA AAAATTGGAA 
     4921 ACATATTCAG GAACTGAAAG CCCCGGCCGC ACTGCCGATT ACCCTGATCG CCGATCGTCC 
     4981 GGACTACACG CAAATTTCAG TTCCGAAATC GGATGCGATC ATGAGCCGCA CCATTTCTAT 
     5041 GCTGATCAAA CTGAGCTGGA CGGACGCTCA GATTGCAGAA CGCATTGAAA ACATTAAGAA 
     5101 GGCATTCGCA CAGTGAGGAT CCAGGAATTC GAGCACCGCT GAGCAATAAC TAGCATAACC 
     5161 CCTTGGGGCC TCTAAACGGG TCTTGAGGGG TTTTTTG 
 
  
